Emollient-treated absorbent interlabial application

ABSTRACT

Absorbent devices, and more particularly absorbent devices that are worn interlabially by female wearers for catamenial purposes, incontinence protection, or both, that have a emollient composition on their body-contacting surface are disclosed. The interlabial device has a body-contacting surface that is pre-moistened or pre-treated with an emollient to prevent drying of the wearer&#39;s labial tissue and to reduce friction of the structure against the wearer&#39;s labial tissue. The absorbent device is preferably capable of maintaining contact with the inside surfaces of the wearer&#39;s labia majora when worn. The emollient composition comprises a plastic or fluid emollient such as mineral oil, petrolatum and/or polysiloxane, an immobilizing agent such as a fatty alcohol or wax to immobilize the emollient on the body-contacting surface of the device, and optionally a hydrophilic surfactant to improve wettability of the coated surface. Because the emollient is substantially immobilized on the surface of the absorbent device, less emollient is required to impart the desired therapeutic or protective emollient coating benefits.

This application is a continuation-in-part of the following patentapplications: Ser. No. 08/706,371 filed Aug. 28, 1996, now U.S. Pat. No.5,885,265; Ser. No. 08/778,521 filed Jan. 3, 1997, now U.S. Pat. No.6,254,584; Ser. No. 08/778,925 filed Jan. 3, 1997, abandoned; and, Ser.No. 08/778,520 filed Jan. 3, 1997, now U.S. Pat. No. 5,895,381.

FIELD OF THE INVENTION

The present invention relates to an absorbent device that is worninterlabially for catamenial purposes, incontinence protection, or both,More particularly, the present invention relates to an interlabialdevice that is pre-moistened or pre-treated with an emollient forimproved comfort.

BACKGROUND OF THE INVENTION

All manner and variety of absorbent articles configured for theabsorption of body fluids such as menses, urine and feces are, ofcourse, well known. With respect to feminine protection devices, the arthas offered two basic types) sanitary napkins have been developed forexternal wear about the pudendal region while tampons have beendeveloped for internal wear within the vaginal cavity for interruptionof menstrual flow therefrom. Such tampon devices are disclosed in U.S.Pat. No. 4,412,833, entitled “Tampon Applicator”, issued to Weigner, etal. on Nov. 1, 1983, and U.S. Pat. No. 4,413,986, entitled “TamponAssembly With Means For Sterile Insertion”, issued to Jacobs on Nov. 8,1983.

Hybrid devices which attempt to merge the structural features of thesanitary napkins and the tampons into a single device have also beenproposed. Such hybrid devices are disclosed in U.S. Pat. No. 2,092,346,entitled “Catamenial Pad”, issued to Arone on Sep. 7, 1937, and U.S.Pat. No. 3,905,372, entitled “Feminine Hygiene Protective Shield”,issued to Denkinger on Sep. 16, 1975. Other less intrusive hybriddevices are known as labial or interlabial sanitary napkins and arecharacterized by having a portion which at least partially resideswithin the wearer's vestibule and a portion which at least partiallyresides external of the wearer's vestibule. Such devices are disclosedin U.S. Pat. No. 2,662,527, entitled “Sanitary Pad”, issued to Jacks onDec. 15, 1953, and U.S. Pat. No. 4,631,062, entitled “Labial SanitaryPad”, issued to Lassen, et al. on Dec. 23, 1986.

Interlabial pads have the potential to provide even greater freedom frominconvenience because of their small size and reduced risk of leakage.Numerous attempts have been made in the past to produce an interlabialpad which would combine the best features of tampons and sanitarynapkins while avoiding at least some of the disadvantages associatedwith each of these types of devices. Examples of such devices aredescribed in U.S. Pat. No. 2,917,049 issued to Delaney on Dec. 15, 1959,U.S. Pat. No. 3,420,235 issued to Harmon on Jan. 7, 1969, U.S. Pat. No.4,595,392 issued to Johnson, et al. on Jun. 17, 1986, and U.S. Pat. No.5,484,429 issued to Vukos, et al. on Jan. 16, 1996. A commerciallyavailable interlabial device is FRESH 'N FIT® PADETTE interlabialproduct which is marketed by Athena Medical Corp. of Portland, OR anddescribed in U.S. Pat. No. 3,983,873 and 4,175,561 issued to Hirschmanon Oct. 5, 1976 and Nov. 27, 1979, respectively.

However, many of these devices have not met with great commercialsuccess. There are drawbacks associated with all of the above products.The devices described in these patents are believed to potentially beuncomfortable to wear due to frictional discomfort associated withrubbing of the product against the labial walls and sticking of thesurfaces of the device to the labial walls. Furthermore, the frictionaldrag and sticking of the body-contacting surface of such devices againstthe labia can prevent these devices from being properly inserted,leading to discomfort.

The problem of drying of a female wearer's labial vestibule area hasbeen discussed in the patent literature. For example, U.S. Pat. No.4,846,824 issued to Lassen, et al. on Jul. 11, 1989, is directed to alabial sanitary pad that has a “physiologically hydrous” cover (that is,a cover material supposedly designed to “maintain a moist interfacebetween the tissues of the vestibule and the pad”). Types of covermaterials specified in the Lassen, et al. patent include a spunlacedpolyester fiber nonwoven and a rayon cover. The Lassen, et al. patentstates that the covers can be provided with various “coatings” tomaintain the physiologically hydrous feature, but no specific coatingsappear to be disclosed.

European Patent Application EP 0 692 263 A2, “Method of reducing thecoefficient of friction of absorbent products and wax coated productsproduced thereby”, is directed to lubricated absorbent products having acoating of a small amount of high molecular weight solid waxy substancewhich has a softening point above body temperature. However, there aredrawbacks associated with the use of high molecular weight materials forthis purpose. High molecular weight materials will not be as soothing orlotion-like to the wearer's skin as lower molecular weight materials. Inaddition, high molecular weight materials will not be capable oftransferring to the wearer's skin to provide skin care benefits. Highmolecular weight waxes can also become brittle and tend to flake or chipoff an absorbent article due to their lack of flexibility if theabsorbent article is of a type that is required to flex and bend.Further, if the softening point of such materials is higher than roomtemperature, application of such materials to an absorbent article willbe more difficult, and will require that the material be heated in orderto coat an absorbent article with such a material.

A vaginal moisture balanced tampon and process is disclosed in EuropeanPatent Application 0 685 215 A1. However, the interlabial device of thepresent invention is not intended to be worn inter-vaginally as atampon.

Thus, a need exists for an interlabial device that is small in size andthat can be easily inserted and that provides protection againstincontinence, menstrual discharges, and discharges of bodily exudatesthroughout a great range of wearer motions. A need exists for aninterlabial device which is absorbent, has a reduction in frictionaldiscomfort associated with rubbing of the product against the labialwalls and sticking of the surfaces of the device to the labial walls. Aneed also exists for an interlabial device that has a reduced tendencyto dry the inside surface of the wearer's labia.

Therefore, it is an object of the present invention to provide aninterlabial device that is small in size and that can be easily insertedand that provides protection against incontinence, menstrual discharges,and discharges of bodily exudates throughout a great range of wearermotions.

It is another object of the present invention to provide an interlabialdevice which is absorbent, but has a reduction in frictional discomfortassociated with rubbing of the product against the labial walls andsticking of the surfaces of the device to the labial walls.

It is another object of the present invention to provide an interlabialdevice that has a reduced tendency to dry the inside surface of thewearer's labia.

It is still another object of the present invention to provide aninterlabial device that can be inserted into the space between thewearer's labia with less friction so that it will more easily be fullyinserted into the desired wearing position.

These and other objects of the present invention will become morereadily apparent when considered in reference to the followingdescription and when taken in conjunction with the accompanyingdrawings.

SUMMARY OF THE INVENTION

This invention relates to absorbent devices, and more particularly to anabsorbent device that is insertable into the interlabial space of afemale wearer for catamenial purposes, incontinence protection, or both.The interlabial device has a body-contacting surface (in particular, asurface contacting the labial vestibule) which is pre-treated with anemollient to prevent drying of the wearer's labial tissue and to reducefriction of the structure against the wearer's labial tissue.

The absorbent interlabial device of the present invention, in onepreferred embodiment, comprises a main absorbent portion and a pair offlexible extensions joined to the main absorbent portion. The mainabsorbent portion preferably comprises an upper portion and a lowerportion opposed to the lower portion. The upper portion faces toward thevestibule floor of the wearer during insertion of the absorbent deviceinto the wearer's interlabial space and during use. That is, the upperportion is positioned furthest inward into the space between thewearer's labia thus leading the lower portion of the absorbent deviceduring insertion. Upon insertion, the lower portion is less fillyinserted into the wearer's interlabial space than the upper portion andthe lower portion faces away from the floor of the vestibule of thewearer. The flexible extensions preferably extend downwardly andoutwardly from the upper portion of the main absorbent portion and arejoined to the same. The flexible extensions are preferably capable ofmaintaining contact with inside surfaces of the wearer's labia andcovering a substantial portion of the same.

At least a portion of said body-contacting surface of the interlabialdevice comprises an effective amount of an emollient coating which ispreferably semisolid or solid at ambient temperature, 68° F. (or 20°C.). The coating preferably comprises a substantially water-freeemollient having a plastic or fluid consistency at 20° C. and comprisinga member selected from the group consisting of petroleum-basedemollients, fatty acid ester emollients, alkyl ethoxylate emollientsand/or polysiloxane emollients, and mixtures thereof In a preferredembodiment, the emollient contains about 5% or less water and comprisesa petroleum based emollient selected from the group consisting ofmineral oil, petrolatum, and mixtures thereof. In an alternate preferredembodiment, the emollient emollient contains about 5% or less water andcomprises a polysiloxane emollient.

The emollient-treated interlabial device provides a reduction infrictional discomfort associated with rubbing of the product against thelabial walls and sticking of the surfaces of the device to the labialwalls. The emollient-treated interlabial device also has a reducedtendency to dry the inside surface of the wearer's labia. Theinterlabial device, because of the presence of the emollient, can beinserted into the space between the wearer's labia with less friction sothat it will more easily be fully inserted into the desired wearingposition.

BRIEF DESCRIPTION OF THE DRAWINGS

While the specification concludes with claims particularly pointing outand distinctly claiming the subject matter which is regarded as formingthe present invention, it is believed that the invention will be betterunderstood from the following description taken in conjunction with theaccompanying drawings, in which:

FIG. 1 is a perspective view of a preferred embodiment of the absorbentinterlabial device of the present invention.

FIG. 2 is an end view of the absorbent device shown in FIG. 1.

FIG. 3 is an end view of a variation of the preferred embodiment shownin FIG. 2.

FIG. 4 is an end view of an alternative preferred embodiment of thepresent invention having a pleated main absorbent portion.

FIG. 5 is an end view of an alternative preferred embodiment of thepresent invention showing a main absorbent portion having a multiplelayer structure.

FIG. 6 is a cross-sectional view of a wearer's body surrounding andincluding the wearer's labia majora and labia minora showing how a priorart interlabial device might fit in the space between the wearer's labiawhen the wearer is standing.

FIG. 7 is a cross-sectional view of the same region of the wearer's bodyshown in FIG. 6 showing how the prior art device might fit when thewearer squats.

FIG. 8 is a cross-sectional view of the same region of the wearer's bodyshown in FIG. 7 showing the flexible extensions of the present inventioncovering the wearer's fingertips as the absorbent device of the presentinvention is inserted into the wearer's interlabial space.

FIG. 9 is a cross-sectional view of the same region of the wearer's bodyshown in FIG. 6 showing how the absorbent interlabial device of thepresent invention fits when the wearer is standing.

FIG. 10 is a cross-sectional view of the same region of the wearer'sbody shown in FIG. 7 which shows how the absorbent interlabial device ofthe present invention fits when the wearer squats.

FIG. 11 is a sectional view of the wearer's body showing how ahypothetical prior art interlabial device that is not treated with anemollient may fit.

FIG. 12 is a sectional view of the wearer's body showing how theemollient-treated interlabial device of the present invention may fit.

FIG. 13 is a schematic perspective view of the Three Point Bend Testapparatus.

FIG. 14 is a plan view of an apparatus suitable for flushabilitydetermination according to the method described in the TEST METHODSsection below.

FIG. 15 is a cross-section of the flushability apparatus of FIG. 14taken along line 15—15 thereof

DETAILED DESCRIPTION OF THE INVENTION

A. The Absorbent Device.

The present invention is directed to an interlabial absorbent article(or “absorbent interlabial structure” or “absorbent interlabial device”)which has a body-contacting surface that is pre-lubricated to preventdrying of the wearer's labial tissue and to reduce friction of thestructure against the wearer's labial tissue. FIGS. 1-3 show onepreferred embodiment of the interlabial absorbent structure of thepresent invention, interlabial device 20. The present invention,however, can be in many other forms, and is not limited to a structurehaving the particular configuration shown in the drawings.

As used herein the term “absorbent interlabial device” refers to astructure which has at least some absorbent components, and isspecifically configured to reside at least partially within theinterlabial space of a female wearer during use. Preferably, more thanone-third, more preferably more than half of the entire absorbentinterlabial device 20 of the present invention resides within suchinterlabial space, more preferably still substantially the entireabsorbent interlabial device 20 resides within such interlabial space,and most preferably the entire absorbent interlabial device 20 resideswithin such interlabial space of a female wearer during use.

As used herein, the term “interlabial space” refers to that space in thepudendal region of the female anatomy which is located between theinside surfaces of the labia majora extending into the vestibule.Located within this interlabial space are the labia minor, the vestibuleand the principal urogenital members including the clitoris, the orificeof the urethra, and the orifice of the vagina. Standard medicalauthorities teach that the vestibule refers to the space boundedlaterally by the inside surfaces of the labia minora and extendinginteriorly to the floor between the clitoris and the orifice of thevagina. Therefore, it will be recognized that the interlabial space asdefined above may refer to the space between the inside surfaces of thelabia majora, including the space between the inside surfaces of thelabia minora also known as the vestibule. The interlabial space forpurposes of the present description does not extend substantially beyondthe orifice of the vagina into the vaginal interior.

The term “labia” as used herein refers generally to both the labiamajora and labia minora. The labia terminate anteriorly and posteriorlyat the anterior commissure and the posterior commissure, respectively.It will be recognized by those skilled in the art that there is a widerange of variation among women with respect to the relative size andshape of labia majora and labial minora. For purposes of the presentdescription, however, such differences need not be specificallyaddressed. It will be recognized that the disposition of the absorbentinterlabial device into the interlabial space of a wearer as definedabove will require placement between the inside surfaces of the labiamajora without regard to the precise location of the boundary betweenthe labia majora and the labia minora for a particular wearer. For amore detailed description of this portion of the female anatomy,attention is directed to Gray's Anatomy, Running Press 1901 Ed. (1974),at 1025-1027.

The absorbent interlabial device 20 shown in FIG. 1 has a longitudinalcenterline L which runs along the “x” axis shown in FIG. 1. The term“longitudinal”, as used herein, refers to a line, axis or direction inthe plane of the interlabial device 20 that is generally aligned with(e.g., approximately parallel to) a vertical plane which bisects astanding wearer into left and right body halves when the interlabialdevice 20 is worn. The terms “transverse,” “lateral,” or “y direction”as used herein, are interchangeable, and refer to a line axis ordirection that is generally perpendicular to the longitudinal direction.The lateral direction is shown in FIG. 1 as the “y” direction. The “z”direction, shown in FIG. 1, is a direction parallel to the verticalplane described above. The term “upper” refers to an orientation in thez-direction toward the wearer's head. “Lower” or downwardly is towardthe wearer's feet.

As shown in FIG. 1, the interlabial device 20 comprises a main absorbentportion (or “central absorbent”) 22, and a pair of flexible extensions24 joined to the main absorbent portion 22. The main absorbent portion22 should be at least partially absorbent. The main absorbent portion 22may comprise non-absorbent portions, such as a liquid impervious barrierto prevent absorbed exudates from leaking out of the main absorbentportion 22. The main absorbent portion 22 comprises an upper portion 26and a lower portion 28 that is opposed to the upper portion. Theflexible extensions 24 are joined to the upper portion 26 of the mainabsorbent portion. In use, the upper portion 26 is positioned furthestinward into the wearer's interlabial space. The interlabial device has abody-facing (or “body-contacting”) surface 20A and a back surface 20B.The body-facing surface 20A can be comprised of at least a portion ofthe absorbent portion 22, at least a portion of the flexible extensions24, or at least a portion of both.

The interlabial device 20 should be of a suitable size and shape thatallows at least a portion thereof to fit comfortably within the wearer'sinterlabial space and to cover the wearer's vaginal orifice, andpreferably also the wearer's urethra. The interlabial device 20 at leastpartially blocks, and more preferably completely blocks and interceptsthe flow of menses, urine, and other bodily exudates from the wearer'svaginal orifice and urethra.

The size of the interlabial device 20 is also important to the comfortassociated with wearing the device. In the preferred embodiment shown inFIG. 1, the main absorbent portion 22 of the interlabial device 20 has alength as measured along the longitudinal centerline, L, of betweenabout 35 mm and about 100 mm. Preferably, the length of the interlabialdevice 20 is between about 45 mm and about 55 mm, and more preferably,is about 49 mm. The caliper (or width) of the main absorbent portion 22of the interlabial device as measured in the transverse direction (or“y”-direction) is preferably less than or equal to about 8 mm, morepreferably the caliper is between about 3 mm and about 6 mm, mostpreferably, the caliper is about 4.5 mm. Caliper measurements givenherein were measured using an AMES gage with a 0.25 psi (gauge) load anda 0.96 inch diameter foot. Those skilled in the art will recognize thatif a 0.96 inch diameter foot is not appropriate for a particular samplesize, the foot size may be varied while the load on the gauge isaccordingly varied to maintain a confining pressure of 0.25 psi (gauge).The height (or “z”-direction dimension) of the main absorbent portion 22is preferably between about 8 mm and about 35 mm, and more preferably isabout 20 mm.

The interlabial device 20 is preferably provided with sufficientabsorbency to absorb and retain the exudates discharged from thewearer's body. The capacity of the product, however, is dependent atleast partially upon the physical volume of the absorbent interlabialdevice 20, particularly the main absorbent portion 22 thereof The mainabsorbent portion 22 preferably has a capacity of at least about 1 g of0.9% by weight saline solution, and may have a capacity of up to about30 g by using absorbent gels or foams that expand when wet. Capacitiesmay typically range from about 2 to about 20 grams, for saline. Inparticularly preferred embodiments, the interlabial device has acapacity of greater than or equal to about 2.5 grams of saline, and morepreferably greater than or equal to about 4 grams of saline. Thoseskilled in the art will recognize that the capacity for absorption ofbody exudates such as menses will typically be smaller than thecapacities given above for absorption of saline. A method for measuringabsorbent capacity is described in the Test Methods section, below.Since the interlabial space can expand, larger volumes can be stored inthe interlabial space, if the fluid is stored as a gel, which adjusts tothe body pressures. Additionally, if the absorbent interlabial device 20does not reside completely within the wearer's interlabial space, someof the absorbed exudates may be stored externally to the wearer'sinterlabial space.

The main absorbent portion 22 of the preferred embodiment shown in FIGS.1-3 may comprise any suitable type of absorbent structure that iscapable of absorbing and/or retaining liquids (e.g. menses and/orurine). The main absorbent portion 22 may be manufactured in a widevariety of shapes. Non-limiting examples include ovoid, trapezoidal,rectangular, triangular, cylindrical, hemispherical or any combinationof the above. The main absorbent portion 22 may, likewise, bemanufactured and from a wide variety of liquid-absorbent materialscommonly used in absorbent articles such as comminuted wood pulp whichis generally referred to as airfelt. Examples of other suitableabsorbent materials include creped cellulose wadding; meltblown polymersincluding coform; chemically stiffened, modified or cross-linkedcellulosic fibers; synthetic fibers such as crimped polyester fibers;peat moss; tissue including tissue wraps and tissue laminates; absorbentfoams; absorbent sponges; superabsorbent polymers; absorbent gellingmaterials; or any equivalent material or combinations of materials, ormixtures of these. Preferred absorbent materials comprise foldedtissues, woven materials, nonwoven webs, needle punched rayon, andlayers or pieces of foam. The main absorbent portion 22 may comprise asingle material or a combination of materials, such as a wrapping layersurrounding a central wadding comprised of a different absorbentmaterial.

In the preferred embodiment shown in FIG. 1, the main absorbent portion22 is formed of a soft absorbent material such as rayon fibers or othersuitable natural or synthetic fibers or sheeting. The main absorbentportion 22 shown in FIG. 1 is generally of an ovoid cross sectionalshape as shown in FIG. 2. The main absorbent portion 22 of theembodiment shown in FIGS. 1 and 2 comprises an upper portion 26 with alarger transverse sectional dimension relative to that of the lowerportion 28. The upper portion 26 is preferably integral with the lowerportion 28. In less preferred embodiments, however, the upper portion 26and lower portion 28 may comprise separate elements joined together byany suitable means know in the art. In the preferred embodiment shown inFIGS. 1 and 2, the juncture of the upper portion 26 and lower portion 28of the main absorbent portion 22 comprises a substantially abrupt changein the transverse dimension thereby forming a shoulder-likeconfiguration at such juncture. In the preferred embodiment shown inFIGS. 1 and 2, the juncture of the upper portion 26 and lower portion 28of the main absorbent portion 22 is formed by stitching 34.

In a variation of the preferred embodiment described above and shown inFIGS. 1 and 2, the upper portion 26 may have a smaller transversesectional dimension relative to the transverse sectional dimension ofthe lower portion 28. An absorbent interlabial device 20 having such aconfiguration is shown in FIG. 3.

The main absorbent portion 22 can be made by any suitable process. U.S.Pat. No. 4,995,150 issued to Gerstenberger et al. on Feb. 26, 1991 andU.S. Pat. No. 4,095,542 issued to Hirschman on Jun. 20, 1978 describemethods for making absorbent devices which are suitable for use as themain absorbent portion 22 of the absorbent interlabial device 20 shownin FIGS. 1-3.

As shown in FIGS. 1-3, a preferred embodiment of the absorbentinterlabial device 20 also comprises a pair of flexible extensions 24which are joined to the upper portion 26 of the main absorbent portion22 of the absorbent interlabial device 20. In the preferred embodimentshown in FIGS. 1-3, the flexible extensions 24 are generally rectangularin shape. Other shapes are also possible for the flexible extensions 24such as semi-circular, trapezoidal, or triangular. The flexibleextensions 24 preferably are from about 30 mm to about 160 mm in length,more preferably from about 45 mm to about 130 mm in length, and mostpreferably from about 50 mm to about 115 mm in length. While theflexible extensions 24 can have a length (measured in the x-direction)which is shorter than the main absorbent portion 22, preferably theyhave a length which is the same as or longer than the main absorbentportion 22 of the absorbent interlabial device 20. The width of eachflexible extensions refers to the distance from the attachment offlexible extension 24 to the main absorbent portion 22 (or the proximalend 24A of the flexible extension 24) to the distal end (or free end)24B of the flexible extension 24. The width of the flexible extensions24 is preferably about equal to or greater than the height of the mainabsorbent portion as described above. The caliper of the flexibleextensions is preferably less than or equal to about 3 mm, morepreferably less than or equal to about 2 mm, and most preferably lessthan or equal to about 1 mm. Ideally, the caliper of the flexibleextensions 24 and the main absorbent portion 22 are selected such thatthe caliper of the overall absorbent interlabial structure 20 is lessthan or equal to about 8 mm.

The flexible extensions 24 may be constructed of a tissue layer. Asuitable tissue is an airlaid tissue available from Fort Howard TissueCompany of Green Bay, Wis., and having a basis weight of 35 lbs./3000sq. ft. Another suitable airlaid tissue is available from Merfin HygenicProducts, Ltd., of Delta, British Columbia, Canada, having a basisweight of 61 g/m² and having the designation grade number 176. Stillanother suitable material is an airlaid cotton batt such as that sold ascosmetic squares by Revco Stores, Inc. of Twinsberg, Ohio. The flexibleextensions 24 may optionally be backed with a layer of material which isimpervious or semi-pervious to body exudates such as, polyethylene,polypropylene, or a polyvinylalchohol.

In the preferred embodiments shown in FIGS. 1-3 the pair of flexibleextensions 24 may comprise a single sheet of material extending toeither side of the longitudinal centerline L of the main absorbentportion 22 of the absorbent interlabial device 20. Alternatively, thepair of flexible extensions 24 may comprise separate sheets of materialindependently joined to the upper portion 26 of the main absorbentportion 22. Preferably, the flexible extensions 24 are arrangedsymmetrically about the longitudinal centerline L of the main absorbentportion 22. The flexible extensions 24 are joined to the upper portion26 of the main absorbent portion 22 of the absorbent interlabial device20. Most preferably, the flexible extensions are joined to the topsurface of the upper portion 26 of the main absorbent portion 22, orwithin about 3 mm of the top surface of the main absorbent portion 22.

The term “joined”, as used herein, encompasses configurations in whichan element is directly secured to another element by affixing theelement directly to the other element; configurations in which theelement is indirectly secured to the other element by affixing theelement to intermediate member(s) which in turn are affixed to the otherelement; and configurations in which one element is integral withanother element; i.e., one element is essentially part of the otherelement.

The flexible extensions 24 may be joined to the upper portion 26 of themain absorbent portion 22 by any variety of means. For example, in thepreferred embodiments shown in FIGS. 1-3 the flexible extensions 24 maybe joined to the upper portion 26 using any suitable adhesive 36centered about the longitudinal centerline L of the main absorbentportion 22 (i.e., on opposite sides of the longitudinal centerline L).The adhesive 36 may extend continuously along the length of the mainabsorbent portion 22 or it may be applied in a “dotted” fashion atdiscrete intervals. Alternatively, the flexible extensions 24 may bejoined to the upper portion 26 of the main absorbent portion 22 bystitching (such as with cotton or rayon thread), thermally bonding,fusion bonding, or any other suitable means known in the art for joiningsuch materials.

As shown in FIGS. 1-3, the flexible extensions 24 are attached to theupper portion 26 of the main absorbent portion 28. The flexibleextensions 24 extend downwardly and outwardly from the main absorbentportion 22 to a free end 24B which is unattached to the main absorbentportion. The flexible extensions 24 may be biased slightly outward fromthe main absorbent portion 22 so as to tend to keep the extensions 24 incontact with the inner surfaces of the labia when the absorbentinterlabial device 20 is in place. Additionally, the naturally moistsurfaces of the labia will have a tendency to adhere to the materialcomprising the flexible extensions 24 further tending to keep them incontact with the inner surfaces of the labia. Preferably the flexibleextensions 24 should be capable of motion from a position where the freeends of the flexible extensions 24 lie adjacent to the main absorbentportion 22 (as shown in FIG. 9) to a position where the flexibleextensions 24 extend directly out from the main absorbent portion 22 inthe transverse direction (as shown in FIG. 4).

The flexible extensions 24 should be of sufficient width and flexibilityto allow the flexible extensions to cover the wearer's fingertips as theabsorbent interlabial device 20 is inserted into the wearer'sinterlabial space. FIG. 8 shows how a wearer may grasp the mainabsorbent portion 22 of the absorbent interlabial device 20 while theflexible extensions 24 remain between the wearer's fingers and her bodyas the device 20 is inserted. Additionally, the flexible extensions 24should be capable of moving with the inner surfaces of the wearer'slabia to maintain contact with the same. The flexible extensions 24 helpkeep the main absorbent portion 22 in place throughout a range of wearermotions such as squatting.

The flexible extensions may be hydrophilic or hydrophobic. The flexibleextensions 24 may be treated to make them less hydrophilic than the mainabsorbent portion 22. The hydrophilicity of a material is generallyexpressed in terms of its contact angle. Thus, the flexible extensions24 may have an advancing contact angle greater than the advancingcontact angle of the main absorbent portion 22, such that fluid ispreferentially directed toward and absorbed by the main absorbentportion 22. The flexible extensions 24 may be either absorbent ornon-absorbent. Preferably, the flexible extensions 24 have at least someabsorbency. However, the majority of the fluid absorbed and retained bythe absorbent interlabial device 20 will preferably ultimately beretained in the main absorbent portion 22. For a more detaileddescription of hydrophilicity and contact angles see the followingpublications which are incorporated by reference herein: The AmericanChemical Society Publication entitled “Contact Angle, Wettability, andAdhesion,” edited by Robert F. Gould, and copyrighted in 1964; andTRI/Princeton Publications, Publication Number 459, entitled “AMicrotechnique for Determining Surface Tension,” published in April1992, and Publication Number 468 entitled, “Determining Contact AnglesWithin Porous Networks,” published in January, 1993, both edited by Dr.H. G. Heilweil.

The stiffness of both the main absorbent portion 22 and the flexibleextensions 24 is important for product comfort. If the main absorbentportion 22 is too flexible, the device is not conveniently or easilyplaced between the folds of the labia, if it is too stiff, the device isuncomfortable and when the user is in a sitting position, the productcan be forced forward against the clitoris causing discomfort. The mainabsorbent portion 22 preferably has a stiffness approximately equal tothat of the products described in U.S. Pat. No. 4,995,150 and 4,095,542.

The strength and stiffness of the flexible extensions 24 are importantcharacteristics of their design. If the flexible extensions 24 have awet burst strength of about less than or equal to 15 grams, they willtend to shred and may leave pieces remaining in the wearer's interlabialspace. Similarly, if the flexible extensions 24 are as stiff as a manilafile folder, they do not provide sufficient flexibility to dynamicallyadjust to the motion of the labia. The stiffness of the flexibleextensions is measured as a bending resistance. Preferably, the flexibleextensions 24 have a bending resistance of less than about 25 gmmeasured using the Three Point Bend Test. More preferably, the flexibleextensions 24 have a bending resistance of less than or equal to about 5gm. A description of the Three Point Bend Test is contained in the TestMethods section, below. The flexible extensions 24 also have an inherentstrength, so that during application and wear they do not tear. The wetstrength for the flexible extensions should exceed 15 grams, andpreferably exceeds 150 grams, and most preferably exceeds 300 grams. Thewet strengths given above are measured using the Wet Burst Test which isdescribed in greater detail in the Test Methods section, below.

In an alternative preferred embodiment shown in FIG. 4, the mainabsorbent portion 22 of the absorbent interlabial device 20 comprises apleated structure. As shown in FIG. 4, the main absorbent portion 22comprises a folded tissue web. The folded tissue web preferably has astrength greater than that of standard non-wet strength toilet tissue.Preferably, the main absorbent portion 22 comprises a tissue having atemporary wet strength of greater than or equal to about 100 g. In apreferred design this wet strength will decay to about 50% or less ofthe original strength over about 30 minutes.

As shown in FIG. 4, the tissue web comprising the main absorbent portion22 is folded into a pleated structure comprising a plurality of pleats30 that are arranged in a laterally side-by-side relationship. Thetissue web can be folded so that it has any suitable number of pleats.Preferably, the tissue web is folded so that the overall caliper (i.e.,the width) of the main absorbent portion 22 of this embodiment isbetween about 2 mm and less than or equal to about 7 mm.

The pleats in the folded tissue web are preferably connected or joined(or retained) in some suitable manner so that the pleated sectionsmaintain their pleated configuration, and are not able to fully open.The pleats can be connected by a variety of means including the use ofthread, adhesives, or heat sealing tissues which contain a thermoplasticmaterial, such as, polyethylene. A preferred design uses stitching whichjoins all of the pleats in the main absorbent portion 22 together.Preferably, the main absorbent structure 22 is provided with five stitchlocations (four at the corners and one additional location approximatelymidway between the two lower corners).

The pleated structure of the main absorbent portion 22 provides severaladvantages. One advantage provided by the pleated structure is thatexudates can penetrate into the pleats of the structure which present alarger and more effective absorbent surface for acquisition than a flatsurface. This is particularly important when dealing with potentiallyviscous fluids and particulate material such as cellular debris andclots which can plug the surface of the structure presented to the body.A second advantage of this design is that the caliper (or width) of theproduct can be easily and conveniently controlled by varying the numberof pleats. The structure shown in FIG. 4 also provides a convenientcentral zone for grasping the product and inserting into the labia,while the body/fingers on the inserting hand are protected fromcontacting the wearer's body.

As noted above for the preferred embodiment shown in FIGS. 1-3, theflexural rigidity of the main absorbent portion 22 is also important forproduct comfort with the pleated structure shown in FIG. 4. An advantageof the pleated structure is that the number, thickness, and tightness ofthe pleats control the stiffness of the structure.

The preferred embodiment shown in FIG. 4, preferably has main absorbentportion 22 and flexible extension 24 dimensions similar to thosedescribed above for the embodiment shown in FIGS. 1-3. The width of themain absorbent portion 22 of the interlabial device 20 as measured inthe transverse direction (y-direction) is preferably between about 2 mmand less than or equal to about 7 mm. Preferably, in a preferredembodiment, the width of the main absorbent portion of the interlabialdevice 20 is about 4.5 mm. As shown in FIG. 4, where the main absorbentportion 22 is of a uniform transverse dimension (i.e., there is noabrupt change in transverse dimension defining the juncture between theupper portion and lower portion) the division between the upper portion26 and lower portion 28 is considered to be at a height equal to aboutone-half of the total height of the main absorbent portion 22.

The pleated design shown in FIG. 4 has the additional benefit of easilyproviding the flexible extensions 24. The extensions 24 can comprise thesame material as the main absorbent portion 22, or they can comprise adifferent material. The extensions 24 are joined to the upper portion 26of the main absorbent portion 22, and most preferably, for thisembodiment, are joined to the top surface of the main absorbent portion22, or within 2 millimeters of the top surface of the main absorbentportion 22. Preferably, in the embodiment shown in FIG. 4, theextensions 24 are integral portions of the main absorbent portion 22(that is, the extensions 24 comprise integral extensions of theabsorbent tissue material that is folded to form the main absorbentportion 22.

The main absorbent portion 22 and the flexible extensions 24 of theabsorbent interlabial device 20 shown in FIG. 4 may be constructed fromany of the materials previously discussed for the embodiments shown inFIGS. 1-3.

The embodiment shown in FIG. 4 can be provided with various optionalfeatures. For example, there may be spacers or high loft or void zonesbetween the pleats to improve the ability of the device 20 to moveexudates downward. Additionally, the pleats on the portion of theproduct contacting the pelvic floor do not need to be of uniform height.For example, the pleated material in the center might be higher and,therefore, easily collapsed under pressure. Such an arrangement canprovide better fit and/or comfort.

In another variation of the pleated structure shown in FIG. 4, the mainabsorbent portion 22 may comprise a plurality of individual layers 32joined in a face-to-face relationship. Such a device is shown in FIG. 5.The structure shown in FIG. 5 may have all of the same characteristicsdescribed above for the pleated structure. One benefit of the use of aplurality of individual layers 32 is that the various layers maycomprise different materials with different properties orcharacteristics. Each of the flexible extensions 24 may be integral withone of the individual layers 32 or may be joined separately to the upperportion 26 of the main absorbent portion 22. Preferably, the individuallayers 32 are arranged in a side-by-side relationship so that the spacesbetween the layers are oriented in the z-direction (as shown in FIG. 5).

The interlabial device 20 in any of the embodiments shown in thedrawings may comprise other optional components. For example, theinterlabial device 20 may comprise a topsheet 42 positioned over andjoined to all or a portion of the body-facing surface of the device 20and/or a backsheet 38 positioned over and joined to all or a portion ofits back surface, including the flexible extensions 24. Preferably, if atopsheet 42 and/or a backsheet 38 is used, these components are joinedto at least a portion of the main absorbent portion. In an alternativeembodiment, the main absorbent portion could be at least partiallywrapped by a topsheet 42.

If a topsheet is used, the topsheet should be compliant, soft feeling,and non-irritating to the wearer's skin. Further, the topsheet should beliquid pervious permitting liquids (e.g., menses and/or urine) toreadily penetrate through its thickness. A suitable topsheet may bemanufactured from a wide range of materials such as woven and nonwovenmaterials; polymeric materials such as apertured formed thermoplasticfilms, apertured plastic films, and hydroformed thermoplastic films;porous foams; reticulated foams; reticulated thermoplastic films; andthermoplastic scrims. Suitable woven and nonwoven materials can becomprised of natural fibers (e.g., wood or cotton fibers), syntheticfibers (e.g., polymeric fibers such as polyester, rayon, polypropylene,or polyethylene fibers) or from a combination of natural and syntheticfibers.

The topsheet may comprise an apertured formed film. Apertured formedfilms are pervious to body exudates and, if properly apertured, have areduced tendency to allow liquids to pass back through and rewet thewearer's skin. Thus, the surface of the formed film which is in contactwith the body remains dry, thereby reducing body soiling and creating amore comfortable feel for the wearer. Suitable formed films aredescribed in U.S. Pat. No. 3,929,135, entitled “Absorptive StructuresHaving Tapered Capillaries”, which issued to Thompson on Dec. 30, 1975;U.S. Pat. No. 4,324,246 entitled “Disposable Absorbent Article Having AStain Resistant Topsheet”, which issued to Mullane, et al. on Apr. 13,1982; U.S. Pat. No. 4,342,314 entitled “Resilient Plastic Web ExhibitingFiber-Like Properties”, which issued to Radel, et al. on Aug. 3, 1982;U.S. Pat. No. 4,463,045 entitled “Macroscopically ExpandedThree-Dimensional Plastic Web Exhibiting Non-Glossy Visible Surface andCloth-Like Tactile Impression”, which issued to Ahr, et al. on Jul. 31,1984; and U.S. Pat. No. 5,006,394“Multilayer Polymeric Film” issued toBaird on Apr. 9, 1991. The preferred topsheet for the present inventionis the formed film described in one or more of the above patents andmarketed on sanitary napkins by The Procter & Gamble Company ofCincinnati, Ohio as the “DRI-WEAVE”topsheet.

In a preferred embodiment of the present invention, the body surface ofthe formed film topsheet is hydrophilic so as to help liquid to transferthrough the topsheet faster than if the body surface was not hydrophilicso as to diminish the likelihood that menstrual fluid will flow off thetopsheet rather than flowing into and being absorbed by the mainabsorbent portion 22. In a preferred embodiment, surfactant isincorporated into the polymeric materials of the formed film topsheet.Alternatively, the body surface of the topsheet can be made hydrophilicby treating it with a surfactant such as is described in U.S. Pat. No.4,950,254 issued to Osborn.

If a backsheet is used, the backsheet could be impervious orsemi-pervious to liquids (e.g., menses and/or urine) and is preferablyflexible. As used herein, the term “flexible” refers to materials whichare compliant and will readily conform to the general shape and contoursof the human body. The backsheet prevents the exudates absorbed andcontained in the main absorbent portion 22 from wetting articles whichcontact the absorbent interlabial device 20 such as the wearer'sundergarments. The backsheet also assists the main absorbent portion 22in preventing the wearer's body from being soiled by exudates.Additionally, use of the backsheet may provide an improved surface forthe wearer to grasp between the fingers as the absorbent interlabialdevice 20 is inserted, or as the device is optionally removed with thefingers.

The backsheet may comprise a woven or nonwoven material, polymeric filmssuch as thermoplastic films of polyethylene or polypropylene, orcomposite materials such as a film-coated nonwoven material. Preferably,the backsheet is a polyethylene film having a thickness of from about0.012 mm (0.5 mil) to about 0.051 mm (2.0 mils). An exemplarypolyethylene film is manufactured by Clopay Corporation of Cincinnati,Ohio, under the designation P18-0401. The backsheet may permit vapors toescape from the main absorbent portion 22 (i.e., breathable) while stillpreventing exudates from passing through the backsheet.

As previously discussed, the absorbent interlabial device 20 of thepresent invention is preferably designed to be placed entirely withinthe interlabial space of a wearer. To use the absorbent interlabialdevice 20 of the present invention, the wearer holds the main absorbentportion 22 between her fingers. As shown in FIG. 8, the flexibleextensions 24 are spread apart so as to cover the tips of the wearer'sfingers during insertion. This feature provides for a hygenic insertionof the absorbent interlabial device 20 of the present invention. Theupper portion 26 is inserted first and furthest into the interlabialspace. The wearer may assume a squatting position during insertion toassist in spreading the labial surfaces. Once the absorbent interlabialdevice 20 is inserted, the flexible extensions 24 tend to adhere to theinside surfaces of the labia. When the wearer is standing, the labialwalls close more tightly around the absorbent interlabial device 20 asshown in FIG. 9.

FIG. 12 shows the interlabial device 20 in place in a wearer's body. Theparts of the wearer's body, W, shown in FIG. 12 are designated asfollows: bladder, B, clitoris, C, urethra, U, labia minora, N, labiamajora, J, vagina, V, vaginal introitus, VI, anus, A, hymenal ring, H,and large intestine, I. The interlabial device 20 is inserted so that itis worn between the wearer's labia minora N and labia majora J andblocks the wearer's vaginal introitus VI without entering the vaginapast the hymenal ring H. That is, the interlabial device 20 lies atleast partially in the vestibule bounded by the labia minora when suchdevice is worn. The interlabial device 20 may also cover, but does notnecessarily occlude, the wearer's urethra U. Preferably, the interlabialdevice 20 covers both the wearer's vaginal introitus VI and the wearer'surethra U. Ideally, the interlabial device 20 is maintained in contactwith as large a portion of the inner surface area of the wearer's labiaminora N and labia majora J as possible. This will ensure that theinterlabial device 20 intercepts as much of the wearer's body exudatesas possible. Preferably, the entire interlabial device 20 is intended tobe worn below the wearer's hymenal ring H.

The interlabial device 20 may also contain a portion that is wornoutside the wearer's labia majora J. This portion could, for example, beused for storage of body exudates that are transferred from the portionof the interlabial device 20 that is worn between the wearer's labiaminora and labia majora. The portion of the interlabial device 20 thatis worn between the wearer's labia minora and labia majora will, as aresult, will have exudates drained therefrom, and be able to receiveadditional loadings of body exudates.

The interlabial device 20 is preferably at least partially retained inplace by exerting a slight laterally outwardly-oriented pressure on theinner surfaces of the wearer's labia minora, labia majora, or both.Additionally, the product is also held by attraction of naturally moistlabial surfaces to the tissue comprising the flexible extensions 24.Optionally, the flexible extensions 24 may be provided with abio-compatible adhesive to assist the adhesion of the flexibleextensions 24 to the inside surfaces of the wearer's labia. The strengthof such an adhesive should be selected to assist the absorbentinterlabial device 20 in staying in place, while still allowing forreliable, and comfortable removal of the device from the wearer'sinterlabial space.

The absorbent interlabial device 20 is believed to differ from the priorart in a number of respects. FIG. 6 shows a prior art interlabial devicepositioned within the interlabial space when the wearer is standing.When the wearer squats, however, the labia tend to separate as shown inFIGS. 7 and 10. The prior art device may tend to shift to one side oranother in such a situation (as shown in FIG. 7). If the wearer urinateswhen the prior art device is in the position shown in FIG. 7, the streamof urine will completely miss the device. The flexible extensions 24 ofthe present invention, however, are adapted to maintain contact with theinside surfaces of the labia in order to keep the absorbent interlabialdevice 20 in proper position (as shown in FIG. 10). This action of theflexible extensions 24 is believed to keep the absorbent interlabialdevice 20 of the present invention in a position which more consistentlyblocks the orifice of the urethra than the prior art device. As aresult, the absorbent interlabial device 20 of the present invention isbelieved to be expelled by urination more reliably than the prior artdevice. As noted previously, the flexible extensions 24 also cover thewearer's fingertips during insertion (as shown in FIG. 8) therebyproviding for a more hygienic insertion than is achieved with the priorart device. Optionally, the absorbent interlabial device 20 may beremoved by grasping the lower portion 28 of the main absorbent portion22 with the fingers. Again, the flexible extensions 24 continue to coverthe fingertips thereby allowing for a more hygienic removal of theabsorbent interlabial device 20 than is achieved with the prior artdevice.

The absorbent interlabial device 20 can be worn as a “stand alone”product. Alternatively, it can be worn as a back up to a tampon, or incombination with a sanitary napkin, pantiliner, or incontinence pad formenstrual or incontinence use. If the absorbent interlabial device 20 isused with a sanitary napkin, the sanitary napkin can be of anythickness. Use with a sanitary napkin may be preferred at night toreduce rear soiling. The interlabial device 20 can be worn inconventional panties, or it can be used with menstrual shorts.

Numerous alternative embodiments of the absorbent interlabial device ofthe present invention are possible. For example, these products aredesigned to be removed by urination, although an alternative extractionstring or loop may be used. These products may also be used withmedicinal treatments. These products may be constructed of materialswhich are biodegradable and/or which will fragment in water withagitation (as in a toilet).

Preferably, the absorbent interlabial device 20 is flushable. As usedherein the terms “flushable and flushability” refer to a product'sability to pass through typical commercially available household toiletsand plumbing drainage systems without causing clogging or similarproblems that can be directly associated with the physical structure ofthe product. It is recognized, however, that there can be manydifferences between the various types of toilets available. Therefore,for the purposes of the appended claims, a test to determine theflushability of a catamenial product, such as an interlabial device, isset out in the TEST METHODS section of this specification.

The absorbent interlabial device 20 may also be constructed with aplurality of slits in the main absorbent portion 22 so as to permitbending of the product in multiple independent directions. Such astructure allows the product to more easily respond to the stressesassociated with body movements. As shown in FIG. 12, in preferredversions of any of the embodiments shown in the prior drawing figures,the upper corner portions 26A and the lower corner portions 28A of theinterlabial device 20 may be rounded to reduce the forces that theproduct transfers to the wearer's body when the wearer sits down. Thetop surface of the structure may also have one or more slits or haveother regions of preferred bending so that product may easily adjust tothe vertical pressure against the pelvic floor, to help accommodate thenon-linear surface of the pelvic floor between the clitoris and theperineum.

The flexible extensions 24 of the absorbent devices above may also actas a spring in both wet and dry conditions such that the sides of theproduct tend to expand outward pressing against the lateral walls of thelabial vestibule, thereby, holding the product in place. In addition, itis preferred that the flexible extensions 24 maintain the ability to actas a “spring” when wet, such as when the product is saturated withliquid. Structures, such as polyurethane foams can provide theseproperties.

B. The Emollient Composition.

The emollient compositions used on the interlabial device of the presentinvention may be solid, liquid, or semisolid at 20° C., i.e. at ambienttemperatures. Preferably, the emollient compositions have a semisolidconsistency that can be described as an unctuous jelly-like consistencyat 20° C. By “semisolid” is meant that the emollient composition has arheology typical of pseudoplastic or plastic fluids. The term “fluid”,as used herein, means liquid (as opposed to gas).

The physical states of the emollient composition and the componentsthereof described herein refer to their states at any time after theproduct is manufactured and the emollient composition is applied to theproduct. Thus, for the purpose of the appended claims, the device willbe considered to be in the claimed state if it is in the state specifiedin storage, on store shelves, or in use. When no shear is applied, theemollient compositions described herein can have the appearance of asemi-solid but can be made to flow as the shear rate is increased. Thisis due to the fact that, while the emollient composition containsprimarily solid components, it also includes some minor liquidcomponents.

If these emollient compositions are solid or semisolid at ambienttemperatures, they will have a reduced tendency to flow and migrate intothe interior of the absorbent interlabial device to which they areapplied. This also allows less emollient composition to be used forimparting softness and smoothing benefits.

When an effective amount of the emollient compositions are applied tothe body-contacting surface of the interlabial device 20, the emollientcompositions described herein impart a soft, lubricious, smooth feelingto the user of the device. This particular feel has also beencharacterized as “silky”, “slick”, “smooth”, etc.

The emollient compositions of the present invention preferably comprise:(1) an emollient(s); (2) an immobilizing agent(s) for the emollient; (3)optionally a hydrophilic surfactant(s); and (4) other optionalcomponents.

1. Emollient

The key active ingredient in these emollient compositions is one or moreemollients. As used herein, an emollient is a material that smoothes,softens, soothes, supples, coats, lubricates, moisturizes, or cleansesthe skin and/or mucous membranes. An emollient typically accomplishesseveral of these objectives such as soothing, moisturizing, andlubricating the skin. For the purposes of the present invention, theseemollients have either a semisolid, a plastic, or a fluid consistency at20° C., i.e., at ambient temperatures. By “plastic consistency” is meantthat the emollient behaves as a non-Newtonian liquid which can be madeto flow when a sufficient shear rate is applied thereto. By “fluidconsistency” is meant that the emollient behaves as a Newtonian liquidwhich flows immediately when stressed, with the the rate of flow beingproportional to the stress. The plastic or fluid emollient consistencyallows the emollient composition to impart a soft, lubricious, smoothingfeel.

The emollients will, therefore, preferably have a softening point atbody temperature, 98.6° F. (37° C.). (Body temperature will be slightlyless in the area of a female wearer's labial vestibule.) Preferably, theemollient composition has at least one component with a peak heatabsorption of less than 99° F. (37° C.). This will ensure that at leastpart of the components will melt below body temperature to provide amore fluid feel and reduced friction against the body. Peak heatabsorption can be measured using a differential scanning calorimeter. Inaddition, in preferred embodiments, the emollients will soften over aspan of temperatures, rather than having a sharp transition at which itchanges from a solid to a liquid. For example, the emollients may beginto soften at about 20° C., or less, and be approximately 80% melted(“melted”, as used herein, means completely liquid) at 38° C. (about100° F.). This will provide the emollient coated device with alubricious feel at body temperatures which will increase as it adjustsfrom ambient temperature to body temperature.

The emollients used in the present invention preferably do not containany high molecular weight hydrocarbon components. If the emollients usedherein contain hydrocarbon components, the molecular weights of suchcomponents are preferably less than 1,500, more preferably less than orequal to about 1,400, and most preferably less than or equal to about1,200. Such emollients will provide more soothing or lotion-likebenefits to the wearer's skin than high molecular weight materials. Theywill also be capable of transferring to the wearer's skin to provideskin care benefits unlike high molecular weight materials. In addition,they will remain flexible when the interlabial device flexes and bends,and will not tend to flake or chip off the interlabial device.

The emollients useful in the present invention are also substantiallyfree of water. Preferably, the overall emollient composition is alsosubstantially free of water. By “substantially free of water” it ismeant that water is not intentionally added to the emollient (oremollient composition). Addition of water to the emollient (or emollientcomposition) is not necessary in preparing or using the emollientcompositions on the present invention and could require an additionaldrying step. However, minor or trace quantities of water in theemollient (or emollient composition) that are picked up as a result of,for example, ambient humidity can be tolerated without adverse effect.Typically, the emollients (and emollient compositions) used in thepresent invention contain about 10% or less water, preferably 5% or lesswater, more preferably about 1% or less water, and most preferably about0.5% or less water.

Emollients useful in the present invention can be petroleum-based, fattyacid ester type, alkyl ethoxylate type, fatty acid ester ethoxylates,fatty alcohol type, polysiloxane, or mixtures of these emollients.Suitable petroleum-based emollients include those hydrocarbons, ormixtures of hydrocarbons, having chain lengths of from 16 to 32 carbonatoms. Petroleum based hydrocarbons having these chain lengths includemineral oil (also known as “liquid petrolatum”) and petrolatum (alsoknown as “mineral wax,” “petroleum jelly” and “mineral jelly”). Mineraloil usually refers to less viscous mixtures of hydrocarbons having from16 to 20 carbon atoms. Petrolatum usually refers to more viscousmixtures of hydrocarbons having from 16 to 32 carbon atoms. Petrolatumis a particularly preferred emollient for emollient compositions for useon the interlabial device of the present invention. Petrolatum has amolecular weight of between about 600 and about 700.

Suitable fatty acid ester type emollients include those derived fromC₁₂-C₂₈ fatty acids, preferably C₁₆-C₂₂ saturated fatty acids, and shortchain (C₁-C₈, preferably C₁-C₃) monohydric alcohols. Representativeexamples of such esters include methyl palmitate, methyl stearate,isopropyl laurate, isopropyl myristate, butyl myristate, butyl stearate,octyl palmitate, isopropyl isostearate, isopropyl palmitate, ethylhexylpalmitate and mixtures thereof Suitable fatty acid ester emollients canalso be derived from monoesters and diesters of both short chain (C₁ toC₁₀) and longer chain fatty alcohols (C₁₂-C₂₈, preferably C₁₂-C₁₆) andshorter chain organic acids e.g., lactic acid, such as lauryl lactateand cetyl lactate. Additional examples include diisopropyl sebacate,dimethyl sebacate, dioctyl sebacate, dibutyl sebacate, diisopropyladipate, and dicapryl adipate. In addition, mixtures of petroleum basedemollients and fatty acid ester emollients, if mixed in the rightproportions, can sometimes provide emollients systems that have asuperior feel compared to the pure components individually.

Suitable alkyl ethoxylate type emollients include C₁₂-C₂₂ fatty alcoholethoxylates having an average degree of ethoxylation of from about 2 toabout 30. Preferably, the fatty alcohol ethoxylate emollient is selectedfrom the group consisting of lauryl, cetyl, and stearyl ethoxylates, andmixtures thereof, having an average degree of ethoxylation ranging fromabout 2 to about 23. Representative examples of such alkyl ethoxylatesinclude laureth-3 (a lauryl ethoxylate having an average degree ofethoxylation of 3), laureth-23 (a lauryl ethoxylate having an averagedegree of ethoxylation of 23), ceteth-10 (a cetyl alcohol ethoxylatehaving an average degree of ethoxylation of 10) steareth-10 (a stearylalcohol ethoxylate having an average degree of ethoxylation of 10), andceteareth-10 (a mixture of cetyl and stearyl ethoxylates having anaverage degree of ethoxylation of 10). These alkyl ethoxylate emollientsare typically used in combination with the petroleum-based emollients,such as petrolatum, at a weight ratio of alkyl ethoxylate emollient topetroleum-based emollient of from about 1:1 to about 1:5, preferablyfrom about 1:2 to about 1:4.

Suitable fatty alcohol type emollients include C₁₂-C₂₂ fatty alcohols,preferably C₁₆-C₁₈ fatty alcohols. Representative examples include cetylalcohol and stearyl alcohol, and mixtures thereof These fatty alcoholemollients are typically used in combination with the petroleum-basedemollients, such as petrolatum, at a weight ratio of fatty alcoholemollient to petroleum-based emollient of from about 1:1 to about 1:5,preferably from about 1:1 to about 1:2.

Other suitable types of emollients for use in the present inventioninclude polysiloxane compounds. In general suitable polysiloxanematerials for use in the present invention include those havingmonomeric siloxane units of the following structure:

wherein, R₁ and R₂, for each independent siloxane monomeric unit caneach independently be hydrogen or any alkyl, aryl, alkenyl, alkaryl,arakyl, cycloalkyl, halogenated hydrocarbon, or other radical. Any ofsuch radicals can be substituted or unsubstituted. R₁ and R₂ radicals ofany particular monomeric unit may differ from the correspondingfunctionalities of the next adjoining monomeric unit. Additionally, thepolysiloxane can be either a straight chain, a branched chain or have acyclic structure. The radicals R₁ and R₂ can additionally independentlybe other silaceous functionalities such as, but not limited tosiloxanes, polysiloxanes, silanes, and polysilanes. The radicals R₁ andR₂ may contain any of a variety of organic functionalities including,for example, alcohol, carboxylic acid, phenyl, and aminefunctionalities.

Exemplary alkyl radicals are methyl, ethyl, propyl, butyl, pentyl,hexyl, octyl, decyl, octadecyl, and the like. Exemplary alkenyl radicalsare vinyl, allyl, and the like. Exemplary aryl radicals are phenyl,diphenyl, naphthyl, and the like. Exemplary alkaryl radicals are toyl,xylyl, ethylphenyl, and the like. Exemplary aralkyl radicals are benzyl,alpha-phenylethyl, beta-phenylethyl, alpha-phenylbutyl, and the like.Exemplary cycloalkyl radicals are cyclobutyl, cyclopentyl, cyclohexyl,and the like. Exemplary halogenated hydrocarbon radicals arechloromethyl, bromoethyl, tetrafluorethyl, fluorethyl, trifluorethyl,trifluorotloyl, hexafluoroxylyl, and the like.

Viscosity of useful polysiloxanes useful may vary as widely as theviscosity of polysiloxanes in general vary, so long as the polysiloxaneis flowable or can be made to be flowable for application to thebody-contacting surface of the interlabial device. This includes, but isnot limited to, viscosity as low as 5 centistokes (at 37° C. as measuredby a glass viscometer) to about 20,000,000 centistokes. Preferably thepolysiloxanes have a viscosity at 37° C. ranging from about 5 to about5,000 centistokes, more preferably from about 5 to about 2,000centistokes, most preferably from about 100 to about 1000 centistokes.High viscosity polysiloxanes which themselves are resistant to flowingcan be effectively deposited upon the body-contacting surface by suchmethods as, for example, emulsifying the polysiloxane in surfactant orproviding the polysiloxane in solution with the aid of a solvent, suchas hexane, listed for exemplary purposes only. Particular methods forapplying polysiloxane emollients to body-contacting surface arediscussed in more detail hereinafter.

Preferred polysiloxanes compounds for use in the present invention aredisclosed in U.S. Pat. No. 5,059,282 (Ampulski, et al), issued Oct. 22,1991, which is incorporated herein by reference. Particularly preferredpolysiloxane compounds for use as emollients in the emollientcompositions include phenyl-functional polymethylsiloxane compounds(e.g., Dow Corning 556 Cosmetic-Grade Fluid: polyphenylmethylsiloxane)and cetyl or stearyl functionalized dimethicones such as Dow 2502 andDow 2503 polysiloxane fluids, respectively. In addition to suchsubstitution with phenyl-functional or alkyl groups, effectivesubstitution may be made with amino, carboxyl, hydroxyl, ether,polyether, aldehyde, ketone, amide, ester, and thiol groups. Of theseeffective substituent groups, the family of groups comprising phenyl,amino, alkyl, carboxyl, and hydroxyl groups are more preferred than theothers; and phenyl-functional groups are most preferred.

Preferably, emollient compositions containing a polysiloxane willfurther comprise a petroleum based emollient selected from the groupconsisting of mineral oil, petrolatum, and mixtures thereof. However,the polysiloxanes emollients described above can also be used alone.

Besides petroleum-based emollients, fatty acid ester emollients, fattyacid ester ethoxylates, alkyl ethoxylate emollients and fatty alcoholemollients, the emollients useful in the present invention can includeminor amounts (e.g., up to about 10% of the total emollient) of other,conventional emollients/solvents. These other, conventionalemollients/solvents include propylene glycol, polyethylene glycol,hexylene glycol, glycerine, triethylene glycol, spermaceti or otherwaxes, fatty acids, and fatty alcohol ethers having from 12 to 28 carbonatoms in their fatty chain, such as stearic acid, propoxylated fattyalcohols; glycerides, acetoglycerides, and ethoxylated glycerides ofC₁₂-C₂₈ fatty acids; other fatty esters of polyhydroxy alcohols; lanolinand its derivatives; silicone polyether copolymers, and polysiloxaneshaving a viscosity at 20° C. of from about 5 to about 2,000 centistokessuch as disclosed in U.S. Pat. No. 5,059,282 (Ampulski et al), issuedOct. 22, 1991, which is incorporated by reference. These otheremollients should be included in a manner such that the solid orsemisolid characteristics of the emollient composition are maintained.

The amount of emollient that can be included in the emollientcomposition will depend on a variety of factors, including theparticular emollient involved, the emollient-like benefits desired, theother components in the emollient composition and like factors. Theemollient composition can comprise from about 5 to about 95% of theemollient. Preferably, the emollient composition comprises from about 10to about 90% by weight, more preferably from 20 to about 80%, mostpreferably from about 40 to about 75%, of the emollient.

2. Immobilizing Agent

An optional component of the emollient compositions useful on theinterlabial device of present invention is an agent capable ofimmobilizing the emollient on the surface of the body-contacting surface20A of the device. Because the emollient in the composition has aplastic or fluid consistency at 20° C., it tends to flow or migrate,even when subjected to modest shear. When applied to an absorbentinterlabial device, especially in a melted or molten state, theemollient will not remain primarily on the body-contacting surface ofthe device. Instead, the emollient will tend to migrate and flow intothe interior of the device.

The need for an immobilizing agent is generally greater of thebody-contacting surface of the interlabial device comprises an absorbentmaterial, such as cellulose, than it is if the body-contacting surfacecomprises an apertured plastic film since the apertured film will nottend to absorb the emollient. The immobilizing agent counteracts thetendency of the emollient to migrate or flow by keeping the emollientprimarily localized on the body-contacting surface of the absorbentinterlabial device. This is believed to be due, in part, to the factthat the immobilizing agent forms hydrogen bonds with any cellulose inthe interlabial device. Through this hydrogen bonding, the immobilizingagent becomes localized on the surface of the interlabial device. Sincethe immobilizing agent is also miscible with the emollient (orsolubilized in the emollient with the aid of an appropriate emulsifier),it entraps the emollient on the surface of the absorbent device as well.

It is also advantageous to “lock” the immobilizing agent on thebody-contacting surface of the interlabial device. This can beaccomplished by using immobilizing agents which quickly solidfy (e.g.,crystallize) at the surface of the interlabial device. Alternatively,outside cooling of the treated interlabial device by the flow of airover the surface of the device when the device is moving rapidly betweenstations on a manufacturing line may speed up crystallization of theimmobilizing agent. In addition, outside cooling of the treatedinterlabial device via blowers, fans, etc. can speed up crystallizationof the immobilizing agent.

In addition to being miscible with (or solubilized in) the emollient,the immobilizing agent preferably has a melting point of at least about35° C. This is so the immobilizing agent itself will not have a tendencyto migrate or flow. Preferred immobilizing agents will have meltingpoints of at least about 40° C. Typically, the immobilizing agent willhave a melting point in the range of from about 50° to about 150° C.

The viscosity of the immobilizing agent should also be as high aspossible to keep the emollient from flowing into the interior of theinterlabial device. Unfortunately, high viscosities can also lead toemollient compositions that are difficult to apply without processingproblems. Therefore, a balance must be achieved so the viscosities arehigh enough to keep the immobilizing agent localized on the surface ofthe interlabial device, but not so high as to cause processing problems.Suitable viscosities for the immobilizing agent will typically rangefrom about 5 to about 200 centipoises, preferably from about 15 to about100 centipoises, measured at 60° C.

Suitable immobilizing agents for the present invention can comprise amember selected from the group consisting of C₁₄-C₂₂ fatty alcohols,C₁₂-C₂₂ fatty acids, and C₁₂-C₂₂ fatty alcohol ethoxylates having anaverage degree of ethoxylation ranging from 2 to about 30, and mixturesthereof Preferred immobilizing agents include C₁₆-C₁₈ fatty alcohols,most preferably selected from the group consisting of cetyl alcohol,stearyl alcohol, and mixtures thereof. Mixtures of cetyl alcohol andstearyl alcohol are particularly preferred. Other preferred immobilizingagents include C₁₆-C₁₈ fatty acids, most preferably selected from thegroup consisting of cetyl acid, stearyl acid, and mixtures thereofMixtures of cetyl acid and stearyl acid are particularly preferred.Still other preferred immobilizing agents include C₁₆-C₁₈ fatty alcoholethoxylates having an average degree of ethoxylation ranging from about5 to about 20. Preferably, the fatty alcohols, fatty acids and fattyalcohols are linear.

Importantly, these preferred immobilizing agents such as the C₁₆-C₁₈fatty alcohols increase the rate of crystallization of the emollientcausing the emollient to crystallize rapidly onto the surface of theinterlabial device. Lower emollient levels can therefore be utilized ora superior feel can be delivered.

Optionally, other types of immobilizing agents can be used incombination with the fatty alcohols, fatty acids, and fatty alcoholethoxylates described above. Typically, only minor amounts of theseother types of immobilizing agents would be used (i.e., up to about 10%of the total immobilizing agent). Examples of these other types ofimmobilizing agents includes polyhydroxy fatty acid esters, polyhydroxyfatty acid amides, waxes (preferably waxes having a molecular weight ofless than 1,500, more preferably less than or equal to 1,400, and mostprefreably less than or equal to about 1,200), and mixtures thereof Tobe useful as immobilizing agents, the polyhydroxy moiety of the ester oramide should have at least one free hydroxy group. It is believed thatthese free hydroxy group(s) are the ones that co-crosslink throughhydrogen bonds with any cellulosic fibers of the interlabial device towhich the emollient composition is applied and homo-crosslink, alsothrough hydrogen bonds, the hydroxy groups of the alcohol, acid, esteror amide, thus entrapping and immobilizing the other components in theemollient matrix. Suitable waxes include, but are not limited tomicrocrystalline waxes, synthetic waxes, such as polyethylene-typewaxes, and silicone waxes.

It is also believed that molecules such as long chain fatty alcohols canorient themselves and interact with one another to form a lamellarstructure. In this lamellar structure, the hydroxyl groups and alkylchains of neighboring alcohol molecules orient and interact with oneanother to form an organized structure. In this “packing arrangement,”the hydroxyl groups of the alcohols form hydrogen bonds with thecellulose polar functionalities (e.g., hydroxy or carbonyl) to“immobilize” the alcohols at the body-contacting surface of theinterlabial device. Since the alcohols are miscible with the preferredemollients, anchoring and/or immobilization of the emollient will occur.

Preferred esters and amides will have three or more free hydroxy groupson the polyhydroxy moiety and are typically nonionic in character.Because of the possible skin sensitivity of those using interlabialdevices to which the emollient composition is applied, these esters andamides should also be relatively mild and non-irritating to the skin.

Suitable polyhydroxy fatty acid esters for use in the present inventionwill have the formula:

wherein R is a C₅-C₃₁ hydrocarbyl group, preferably straight chainC₇-C₁₉ alkyl or alkenyl, more preferably straight chainC₉-C_(17 alkyl or alkenyl, most preferably straight chain C) ₁₁-C₁₇alkyl or alkenyl, or mixture thereof, Y is a polyhydroxyhydrocarbylmoiety having a hydrocarbyl chain with at least 2 free hydroxylsdirectly connected to the chain; and n is at least 1. Suitable Y groupscan be derived from polyols such as glycerol, pentaerythritol; sugarssuch as raffinose, maltodextrose, galactose, sucrose, glucose, xylose,fructose, maltose, lactose, mannose and erythrose; sugar alcohols suchas erythritol, xylitol, malitol, mannitol and sorbitol; and anhydridesof sugar alcohols such as sorbitan.

One class of suitable polyhydroxy fatty acid esters for use in thepresent invention comprises certain sorbitan esters, preferably thesorbitan esters of C₁₆-C₂₂ saturated fatty acids. Because of the mannerin which they are typically manufactured, these sorbitan esters usuallycomprise mixtures of mono-, di-, tri-, etc. esters. Representativeexamples of suitable sorbitan esters include sorbitan palmitates (e.g.,SPAN 40), sorbitan stearates (e.g., SPAN 60), and sorbitan behenates,that comprise one or more of the mono-, di- and tri-ester versions ofthese sorbitan esters, e.g., sorbitan mono-, di- and tri-palmitate,sorbitan mono-, di- and tri-stearate, sorbitan mono-, di andtri-behenate, as well as mixed tallow fatty acid sorbitan mono-, di- andtri-esters. Mixtures of different sorbitan esters can also be used, suchas sorbitan palmitates with sorbitan stearates. Particularly preferredsorbitan esters are the sorbitan stearates, typically as a mixture ofmono-, di- and tri-esters (plus some tetraester) such as SPAN 60, andsorbitan stearates sold under the trade name GLYCOMUL-S by Lonza, Inc.Although these sorbitan esters typically contain mixtures of mono-, di-and tri-esters, plus some tetraester, the mono- and di-esters areusually the predominant species in these mixtures.

Another class of suitable polyhydroxy fatty acid esters for use in thepresent invention comprises certain glyceryl monoesters, preferablyglyceryl monoesters of C₁₆-C₂₂ saturated fatty acids such as glycerylmonostearate, glyceryl monopalmitate, and glyceryl monobehenate. Again,like the sorbitan esters, glyceryl monoester mixtures will typicallycontain some di- and triester. However, such mixtures should containpredominantly the glyceryl monoester species to be useful in the presentinvention.

Another class of suitable polyhydroxy fatty acid esters for use in thepresent invention comprise certain sucrose fatty acid esters, preferablythe C₁₂-C₂₂ saturated fatty acid esters of sucrose. Sucrose monoestersare particularly preferred and include sucrose monostearate and sucrosemonolaurate.

Suitable polyhydroxy fatty acid amides for use in the present inventionwill have the formula:

wherein R¹ is H, C₁-C₄ hydrocarbyl, 2-hydroxyethyl, 2-hydroxypropyl,methoxyethyl, methoxypropyl or a mixture thereof, preferably C₁-C₄alkyl, methoxyethyl or methoxypropyl, more preferably C₁ or C₂ alkyl ormethoxypropyl, most preferably C₁ alkyl (i.e., methyl) or methoxypropyl;and R^(2 is a C) ₅-C₃₁ hydrocarbyl group, preferably straight chainC₇-C₁₉ alkyl or alkenyl, more preferably straight chain C₉-C₁₇ alkyl oralkenyl, most preferably straight chain C₁₁-C₁₇ alkyl or alkenyl, ormixture thereof; and Z is a polyhydroxyhydrocarbyl moiety having alinear hydrocarbyl chain with at least 3 hydroxyls directly connected tothe chain. See U.S. Pat. No. 5,174,927 (Honsa), issued Dec. 29, 1992(herein incorporated by reference) which discloses these polyhydroxyfatty acid amides, as well as their preparation.

The Z moiety preferably will be derived from a reducing sugar in areductive amination reaction; most preferably glycityl. Suitablereducing sugars include glucose, fructose, maltose, lactose, galactose,mannose, and xylose. High dextrose corn syrup, high fructose corn syrup,and high maltose corn syrup can be utilized, as well as the individualsugars listed above. These corn syrups can yield mixtures of sugarcomponents for the Z moiety.

The Z moiety preferably will be selected from the group consisting of—CH₂—(CHOH)_(n)—CH₂OH, —CH(CHOH)—[(CHOH)_(n—1)]—CH₂OH,—CHOH—CH₂—(CHOH)₂(CHOR³)(CHOH)—CH₂OH, where n is an integer from 3 to 5,and R³ is H or a cyclic or aliphatic monosaccharide. Most preferred arethe glycityls where n is 4, particularly —CH₂—(CHOH)₄—CH₂OH.

In the above formula, R¹ can be, for example, N-methyl, N-ethyl,N-propyl, N-isopropyl, N-butyl, N-2-hydroxyethyl, N-methoxypropyl orN-2-hydroxypropyl,. R² can be selected to provide, for example,cocamides, stearamides, oleamides, lauramides, myristamides,capricamides, palmitamides, tallowamides, etc. The Z moiety can be1-deoxyglucityl, 2-deoxyfructityl, 1-deoxymaltityl, 1-deoxylactityl,1-deoxygalactityl, 1-deoxymannityl, 1-deoxymaltotriotityl, etc.

The most preferred polyhydroxy fatty acid amides have the generalformula:

wherein R¹ is methyl or methoxypropyl; R² is a C₁₁-C₁₇ straight-chainalkyl or alkenyl group. These include N-lauryl-N-methyl glucamide,N-lauryl-N-methoxypropyl glucamide, N-cocoyl-N-methyl glucamide,N-cocoyl-N-methoxypropyl glucamide, N-palmityl-N-methoxypropylglucamide, N-tallowyl-N-methyl glucamide, or N-tallowyl-N-methoxypropylglucamide.

As previously noted, some of the immobilizing agents require anemulsifier for solubilization in the emollient. This is particularly thecase for certain of the glucamides such as the N-alkyl-N-methoxypropylglucamides having HLB values of at least about 7. Suitable emulsifierswill typically include those having HLB values below about 7. In thisregard, the sorbitan esters previously described, such as the sorbitanstearates, having HLB values of about 4.9 or less have been found usefulin solubilizing these glucamide immobilizing agents in petrolatum. Othersuitable emulsifiers include steareth-2 (polyethylene glycol ethers ofstearyl alcohol that conform to the formula CH₃(CH₂)₁₇(OCH₂CH₂)_(n)OH,where n has an average value of 2), sorbitan tristearate, isosorbidelaurate, and glyceryl monostearate. The emulsifier can be included in anamount sufficient to solubilize the immobilizing agent in the emollientsuch that a substantially homogeneous mixture is obtained. For example,an approximately 1:1 mixture of N-cocoyl-N-methyl glucamide andpetrolatum that will normally not melt into a single phase mixture, willmelt into a single phase mixture upon the addition of 20% of a 1:1mixture of steareth-2 and sorbitan tristearate as the emulsifier.

The amount of immobilizing agent that should be included in theemollient composition will depend on a variety of factors, including theparticular emollient involved, the particular immobilizing agentinvolved, whether an emulsifier is required to solubilize theimmobilizing agent in the emollient, the other components in theemollient composition and like factors. The emollient composition cancomprise from about 5 to about 80% of the immobilizing agent.Preferably, the emollient composition comprises from about 5 to about50%, most preferably from about 10 to about 40%, of the immobilizingagent.

3. Optional Hydrophilic Surfactant

The interlabial device of the present invention is preferably disposedof by flushing the same down a conventional toilet. In such cases, itmay be desirable that the interlabial device be sufficiently wettable sothat it will not float. Depending upon the particular immobilizing agentused in the emollient composition, an additional hydrophilic surfactant(or a mixture of hydrophilic surfactants) may, or may not, be requiredto improve wettability. For example, some immobilizing agents, such asN-cocoyl-N-methoxypropyl glucamide have HLB values of at least about 7and are sufficiently wettable without the addition of hydrophilicsurfactant. Other immobilizing agents such as the C₁₆-C₁₈ fatty alcoholshaving HLB values below about 7 may require addition of hydrophilicsurfactant to improve wettability. Similarly, a hydrophobic emollientsuch as petrolatum may require the addition of a hydrophilic surfactant.

Suitable hydrophilic surfactants are preferably miscible with theemollient and the immobilizing agent so as to form homogeneous mixtures.Because of possible skin sensitivity of those using the interlabialdevice, these surfactants should also be relatively mild andnon-irritating to the skin. Typically, these hydrophilic surfactants arenonionic to be non-irritating to the skin.

Suitable nonionic surfactants are preferably substantially nonmigratoryafter the emollient composition is applied to the interlabial device andwill typically have HLB values in the range of from about 4 to about 20,preferably from about 7 to about 20. To be nonmigratory, these nonionicsurfactants will typically have melt temperatures greater than thetemperatures commonly encountered during storage, shipping,merchandising, and use of absorbent articles, e.g., at least about 30°C. In this regard, these nonionic surfactants will preferably havemelting points similar to those of the immobilizing agents previouslydescribed.

Suitable nonionic surfactants for use in emollient compositions includealkylglycosides; alkylglycoside ethers as described in U.S. Pat. No.4,011,389 (Langdon, et al), issued Mar. 8, 1977; alkylpolyethoxylatedesters such as Pegosperse 1000MS (available from Lonza, Inc., Fair Lawn,N.J.), ethoxylated sorbitan mono-, di- and/or tri-esters of C₁₂-C₁₈fatty acids having an average degree of ethoxylation of from about 2 toabout 20, preferably from about 2 to about 10, such as TWEEN 60(sorbitan esters of stearic acid having an average degree ofethoxylation of about 20) and TWEEN 61 (sorbitan esters of stearic acidhaving an average degree of ethoxylation of about 4), and thecondensation products of aliphatic alcohols with from about 1 to about54 moles of ethylene oxide. The alkyl chain of the aliphatic alcohol istypically in a straight chain (linear) configuration and contains fromabout 8 to about 22 carbon atoms. Particularly preferred are thecondensation products of alcohols having an alkyl group containing fromabout 11 to about 22 carbon atoms with from about 2 to about 30 moles ofethylene oxide per mole of alcohol. Examples of such ethoxylatedalcohols include the condensation products of myristyl alcohol with 7moles of ethylene oxide per mole of alcohol, the condensation productsof coconut alcohol (a mixture of fatty alcohols having alkyl chainsvarying in length from 10 to 14 carbon atoms) with about 6 moles ofethylene oxide. A number of suitable ethoxylated alcohols arecommercially available, including TERGITOL 15-S-9 (the condensationproduct of C₁₁-C₁₅ linear alcohols with 9 moles of ethylene oxide),marketed by Union Carbide Corporation; KYRO EOB (condensation product ofC₁₃-C₁₅ linear alcohols with 9 moles of ethylene oxide), marketed by TheProcter & Gamble Co., the NEODOL brand name surfactants marketed byShell Chemical Co., in particular NEODOL 25-12 (condensation product ofC₁₂-C₁₅ linear alcohols with 12 moles of ethylene oxide) and NEODOL23-6.5T (condensation product of C₁₂-C₁₃ linear alcohols with 6.5 molesof ethylene oxide that has been distilled (topped) to remove certainimpurities), and especially the PLURAFAC brand name surfactants marketedby BASF Corp., in particular PLURAFAC A-38 (a condensation product of aC₁₈ straight chain alcohol with 27 moles of ethylene oxide). (Certain ofthe hydrophilic surfactants, in particular ethoxylated alcohols such asNEODOL 25-12, can also function as alkyl ethoxylate emollients). Otherexamples of preferred ethoxylated alcohol surfactants include ICI'sclass of Brij surfactants and mixtures thereof, with Brij 76 (i.e.,Steareth-10) and Brij 56 (i.e., Cetyl-10) being especially preferred.Also, mixtures of cetyl alcohol and stearyl alcohol ethoxylated to anaverage degree of ethoxylation of from about 10 to about 20 may also beused as the hydrophilic surfactant.

Another type of suitable surfactant for use in the present inventionincludes Aerosol TO, a dioctyl ester of sodium sulfosuccinic acidmarketed by American Cyanamid Company.

Still another type of suitable surfactant for use in the presentinvention includes silicone copolymers such as General Electric SF 1188(a copolymer of a polydimethylsiloxane and a polyoxyalkylene ether) andGeneral Electric SF 1228 (a silicone polyether copolymer). Thesesilicone surfactants can be used in combination with the other types ofhydrophilic surfactants discussed above, such as the ethoxylatedalcohols. These silicone surfactants have been found to be effective atconcentrations as low as 0.1%, more preferably from about 0.25 to about1.0%, by weight of the emollient composition.

The amount of hydrophilic surfactant required to increase thewettability of the emollient composition to a desired level will dependupon the HLB value and level of immobilizing agent used, the HLB valueof the surfactant used and like factors. The emollient composition cancomprise from about 1 to about 50% of the hydrophilic surfactant whenneeded to increase the wettability properties of the composition.Preferably, the emollient composition comprises from about 1 to about25%, most preferably from about 10 to about 20%, of the hydrophilicsurfactant when needed to increase wettability.

It is also possible that a surfactant can be used which is separatelyapplied to the interlabial device, and is not included in the emollientcomposition. If a surfactant is separately applied to the interlabialdevice, it is preferably applied to the back surface 20B of the same sothat it does not come in contact with the wearer's body. In otherembodiments, particularly where the interlabial device is not providedwith a liquid impervious backsheet, the surfactant could be eliminatedaltogether. In such cases, the interlabial device will be sufficientlywettable that it is flushable. The back surface of such an interlabialdevice will typically not have an emollient coating thereon, and willreadily wet and sink when placed in a toilet.

4. Other Optional Components

Emollient compositions can comprise other optional components typicallypresent in emollient, creams, and emollients of this type. Theseoptional components include water, viscosity modifiers, pH modifiers,buffers, perfumes, disinfectant antibacterial actives, pharmaceuticalactives, film formers, deodorants, opacifiers, astringents, solvents,organic acids, preservatives, anti-viral actives, drugs, vitamins, aloevera, panthenol, and the like. In addition, stabilizers can be added toenhance the shelf life of the emollient composition such as cellulosederivatives, proteins and lecithin. All of these materials are wellknown in the art as additives for such formulations and can be employedin appropriate amounts in the emollient compositions for use in thepresent invention.

C. Treating the Interlabial Structure With Emollient Composition.

The body-contacting surface of the interlabial device 20 is pre-treated.The body-contacting surface 20A is treated with a substance or anemollient (such as a liquid) which is suitable for contact with thewearer's skin and which will help or aid in maintaining the hydrationlevel of the labial tissue and reduce friction therewith.

In preparing lotioned interlabial products of the present invention, theemollient composition is applied to the body-contacting surface 20A ofthe interlabial product. Any of a variety of application methods thatevenly distribute lubricious materials having a molten or liquidconsistency can be used. Suitable methods include spraying, printing(e.g., flexographic printing), coating (e.g., gravure coating),extrusion, or combinations of these application techniques, e.g.spraying the emollient composition on a rotating surface, such as acalender roll, that then transfers the composition to thebody-contacting surface of the interlabial device 20.

The manner of applying the emollient composition to the interlabialdevice should be such that the body-contacting surface 20A does notbecome saturated with the emollient composition. If the body-contactingsurface 20A becomes saturated with the emollient composition, there is agreater potential for the emollient to block the pores or other openingsin the body-contacting surface, reducing the ability to transmit fluidthrough the body-contacting surface to the absorbent portions of theinterlabial device. Also, saturation of the body-contacting surface 20Ais not required to obtain the benefits described herein.

The emollient composition is preferably applied to the body-contactingsurface 20A of the interlabial device in an amount ranging from about0.1 mg/cm² to about 30 mg/cm² more preferably from about 1 mg/cm² toabout 15 mg/cm² (mg of emollient per square centimeter of coatedbody-contacting surface). Because the emollient is substantiallyimmobilized on the surface of the body-contacting surface, lessemollient composition is needed to impart the desired benefits. Suchrelatively low levels of emollient composition are adequate to impartthe desired benefits to the interlabial device, yet do not saturate theinterlabial device's absorbency and/or wettability properties.

The emollient composition may be applied to the entire body-contactingsurface of the interlabial device, or portions thereof For example, theemollient composition may be applied to the body-contacting portion ofthe main absorbent portion, to the body-contacting portion of theflexible extensions, or to the body-contacting portion of both the mainabsorbent portion and the flexible extensions. Preferably, the emollientcomposition is applied to the body-contacting portion of both the mainabsorbent portion and any flexible extensions.

The emollient composition can also be applied nonuniformly to thebody-contacting surface of the interlabial device. By “nonuniform” ismeant that the amount, pattern of distribution, etc. of the emollientcomposition can vary over the body-contacting surface. For example, someportions of the body-contacting surface can have greater or lesseramounts of emollient composition, including portions of the surface thatdo not have any emollient composition on it. If the emollient is appliednonuniformly, the levels of the emollient specified above are preferablyaverages of the amount of coating applied to the entire surface.

The emollient composition can be applied to the interlabial device atany point during assembly. For example, the emollient composition can beapplied to the body-contacting surface of the finished interlabialdevice before it has been packaged. The emollient composition can alsobe applied to components of the interlabial device before they arecombined with the other raw materials to form the finished interlabialdevice.

The emollient composition may be applied from a melt thereof to thebody-contacting surface of the interlabial device. If the emollientcomposition melts at a temperature above ambient temperatures, it can beapplied as a heated coating to the body-contacting surface. Typically,the emollient composition is heated to a temperature in the range fromabout 35° to about 100° C., preferably from 40° to about 90° C., priorto being applied to the body-contacting surface of the interlabialdevice. Once the melted emollient composition has been applied to thebody-contacting surface of the interlabial device, it is allowed to cooland solidify to form solidified coating or film on the body-contactingsurface. Preferably, the application process is designed to aid in thecooling/set up of the emollient.

In applying the emollient composition to interlabial devices, spraying,gravure coating and extrusion coating methods are preferred. Onepreferred method, when the interlabial device is provided with atopsheet, is spraying the emollient on the topsheet before the topsheetis assembled with the other raw materials into the finished product. Incarrying out this method, a web of topsheet material is unwound fromparent topsheet roll and advanced to a spray station where one side ofthe web is sprayed with a hot, molten (e.g., 65° C.) emollientcomposition. After leaving spray station, the web of topsheet materialbecomes an emollient-treated topsheet which is thereafter used in theassembly of the finished product.

An alternative preferred method involves continuous or intermittentspraying of the emollient composition on the body-contacting surface ofthe assembled or partially assembled interlabial device. When it is saidthat the emollient composition can be applied to a partially assembledinterlabial device, there are a number of ways this can be accomplished.These include, but are not limited to the following. If the interlabialdevice is provided with flexible extensions, the web of material that isconverted into the flexible extensions can be treated before thematerial is joined to the main absorbent portion to form the interlabialdevice. The main absorbent portion could similarly be treated separatelybefore the flexible extensions are joined thereto. In this regard, it iscontemplated that the main absorbent portion will initially be in theform of a continuous rope-like web that will be intermittently cut intodiscrete lengths to form a plurality of main absorbent portions. It willoften be most convenient to treat the main absorbent portion before itis cut into discrete lengths.

In treating the interlabial device by spraying the emollient onto theassembled or partially assembled device, the interlabial device ordesired portion or component thereof can be carried in any suitablemanner to a spray station where the body-contacting surface of theinterlabial device is sprayed with a hot, molten (e.g., 65° C.)emollient composition. After leaving the spray station, the interlabialdevice has an emollient coated body-contacting surface. The amount ofemollient composition transferred to body-contacting surface can becontrolled by: (1) the rate at which the molten emollient composition issprayed from spray station; and/or (2) the speed at which theinterlabial device travels under the spray station.

Providing the interlabial device with a coating of emollient provides anumber of advantages. The emollient-treated absorbent device provides areduction in frictional discomfort associated with rubbing of the deviceagainst the labial walls and sticking of the surfaces of the device tothe labial walls. The interlabial device also has less of a dryingsensation to the inside surfaces of the wearer's labia due to thepresence of the emollient. In addition, as shown by comparing FIGS. 11and 12, the interlabial device can be inserted into the space betweenthe wearer's labia with less friction so that it will more easily befully inserted into the desired wearing position.

FIG. 11 shows a hypothetical example of a prior art interlabial devicethat is not treated with an emollient. FIG. 11 shows a prior artinterlabial pad in place in a wearer's body. When the user attempts toinsert such the device, the friction between the body-contacting surfaceof the device and the inside walls of the wearer's labia may prevent thedevice from being fully inserted as shown in FIG. 11. This may preventthe device from providing maximum protection against leakage. It mayalso result in portions of the lower portion of the device, such aslower corner portions 28A, remaining outside the labial vestibule. Whenthe wearer sits, these lower corner portions 28A may be pressed upwardcausing discomfort to the wearer.

FIG. 12 shows how, on the other hand, the emollient-treated interlabialdevice of the present invention will tend to be capable of being morefully inserted into the labial vestibule so that the lower cornerportions reside completely inside the wearer's labial vestibule.

Another advantage of the interlabial device of the present invention isthat the emollients described herein are substantially free of water.Hydrous emollients are less preferred because such materials can supportbacterial growth during storage of the product prior to shipment to theconsumer.

In other embodiments, the emollients described herein could be appliedto other types of absorbent articles, particularly other types offeminine hygiene articles, such as sanitary napkins, panty liners,incontinence devices, and tampons. The relatively lower molecular weightand melting temperature of the emollients described herein make themparticularly suitable for use with absorbent articles that have anapertured film topsheet such as those topsheet materials describedabove. Without wishing to be bound to any particular theory this isbelieved to be so because such topsheets will not have fibers which helpmaintain the coating thereon by the emollient embedding into the spacesbetween the same. Higher molecular weight and higher melting pointtemperature materials will typically readily flake off apertured films,when such films are flexed.

The disclosure of all patents, patent applications (and any patentswhich issue thereon, as well as any corresponding published foreignpatent applications), and publications mentioned throughout thisdescription are hereby incorporated by reference herein. It is expresslynot admitted, however, that any of the documents incorporated byreference herein teach or disclose the present invention.

TEST METHODS Absorbent Capacity

Absorbent capacity may be determined as follows. The test is performedon samples that have been conditioned by leaving them in a room at 50%relative humidity and at 73°F. for a period of two hours prior to thetest. The test should be performed under similar conditions.

The article is weighed to the nearest 0.1 gram. The article is thensubmerged in a beaker of sterile 0.9% saline solution (obtainable fromthe Baxter Travenol Company of Deerfield, Ill.), such that the articleis totally submerged and is not bent or otherwise twisted or folded. Thearticle is submerged for 10 minutes. The article is removed from thesaline and laid horizontally on a wire mesh screen having squareopenings 0.25 inches by 0.25 inches (0.64 cm by 0.64 cm) for fiveminutes to allow the saline to drain out to the article. Both sides ofthe article are then covered with absorbent blotters, such as the filterpaper #631 available from the Filtration Science Corp., Eaton-DikemanDivision of Mount Holly Springs, Pa. A uniform 17.6 grams per squarecentimeter load is placed over the article to squeeze excess fluid out.The absorbent blotters are replaced every 30 seconds until the amount offluid transferred to the absorbent blotters is less than 0.5 grams in a30 second period. Next, the article is weighed to the nearest 0.1 gramand the dry weight of the article is subtracted. The difference in gramsis the absorbent capacity of the article.

Three Point Bend Test

The The ree Point Bend Test is performed on s amp les that have beenconditioned by leaving them in a room at 50% relative humidity and at73° F. for a period of two hours prior to the test. The test should beperformed under similar conditions.

The three point bend test uses an INSTRON Model 4502 tensile andcompression testing machine, which is available from Instron Corporationof Canton, Mass. The test also uses a special displacement “T-rod” and aspecial test sample holder. As shown in FIG. 13, the “T-rod” 1101comprises a pair of 6.40 mm diameter metal rods perpendicularly mountedtogether. The drive rod 1102 is about 125 mm long and the push rod 1103is about 75 mm long. Preferably, the end of the drive rod 1102 istapered to fit the circumference of the push rod 1103 and the two areglued, welded and/or screwed to each other. The opposite end of thedrive rod 1102 is mounted to the crosshead unit of the INSTRON machine.The test sample holder 1104 comprises a fixture base 1105 forpositioning and supporting a pair of supporting rods 1108. The fixturebase 1105 comprises a base 1105 and two rectangular supports 1107mounted in parallel on the base 1106. The base 1106 and the supports1107 are each preferably made of LEXAN (plexiglas) plate of about 10 mmto about 13 mm thickness. A supporting rod 1108 of the same materials asthe “T-bar” and about 150 mm long is mounted on each support 1107 of thefixture base 1105. The supporting rods 1108 are mounted so as to leave10 mm of open space between them (measured at the point on each rodwhich is closest to the other). As shown in FIG. 13, the “T-rod” 1101 iscentered between the supporting rods 1108.

The INSTRON machine is set for a crosshead speed of 2.0 in/min (50.8mm/min). The INSTRON machine is set up so that the crosshead unit willtravel 10 mm down and back for each sample tested.

Prior to testing of a sample, the T-rod 1101 is lowered until it isresting directly on top on one of the supporting rods 1108. The verticalposition of the T-rod 1101 is “zeroed” when the load as it rests onsupporting rod 1108 is about 1 gramf The T-rod 1101 is then raised 5 mmfrom this zero position and centered between both supporting rods 1108.

The sample 1000 to be tested can be a piece of material taken from oneof the flexible extensions. The sample 1000 taken from the flexibleextensions should have a dimension of about 25 mm in the longitudinaldirection LD and a dimension in the transverse direction of about 10 mm.If the flexible extensions on the product to be tested are too small, alarger sample of the same material should be used for the test. Thesample is placed so that the push rod 1103 is running parallel to a sideof the sample that was oriented in the transverse direction TD.

The T-rod 1101 is then allowed to travel through a complete 10 mm cycle(i.e., 10 mm down and 10 mm back up). Consequently, the T-rod 1101 willmake contact with the sample 1000 after about 5 mm and bend the sampleabout an additional 5 mm. The bending resistance is the peak forcerequired to bend the sample as the T-rod travels through a complete 10mm cycle.

Burst Strength Test

Overview

A test specimen, held between annular clamps, is subjected to increasingforce that is applied by a 0.625 inch diameter, polished stainless steelball. The burst strength is that force that causes the sample to fail.Burst strength may be measured on wet or dry samples.

Apparatus

Burst Tester Intelect-II-STD Tensile Test Instrument, Cat. No.1451-24PGB or the Thwing-Albert Burst Tester are both suitable. Bothinstruments are available from Thwing-Albert Instrument Co.,Philadelphia, PA. The instruments must be equipped with a 2000 g loadcell and, if wet burst measurements are to be made, the instruments mustbe equipped with a load cell shield and a front panel water shield.Conditioned Room Temperature and humidity should be controlled to remainwithin the following limits: Temperature: 73 ± 3° F. (23° C. ± 2° C.)Humidity: 50 ± 2% Relative Humidity Paper Cutter Scissors or otherequivalent may be used Pan For soaking wet burst samples, suitable tosample size Solution Water for soaking wet burst samples should beequilibrated to the temperature of the conditioned room. TimerAppropriate for measuring soak time

Sample preparation

1) Cut the sample to a size appropriate for testing (minimum sample size4.5 in×4.5 in). If the sample to be tested is too small (e.g., aflexible extension with overall dimensions less than 4.5 in×4.5 in) alarger sample of the same material should be used to determine wet burststrength. Prepare a minimum of five samples for each condition to betested.

2) If wet burst measurements are to be made, place an appropriate numberof cut samples into a pan filled with temperature-equilibrated water.

Equipment Setup

1) Set the burst tester up according to the manufacturer's instructions.If an Intelect-II-STD Tensile Test Instrument is to be used thefollowing are appropriate:

Speed: 12.7 centimeters per minute

Break Sensitivity: 20 grams

Peak Load: 2000 grams

2) Calibrate the load cell according to the expected burst strength.

Measurement and Reporting

1) Operate the burst tester according to the manufacturer's instructionsto obtain a burst strength measurement for each sample.

2) Record the burst strength for each sample and calculate an averageand a standard deviation for the burst strength for each condition.

3) Report the average and standard deviation for each condition to thenearest gram.

Report the average and the standard deviation for each group of foursamples.

This concludes the test.

Water Dispersion Test

Apparatus

Stirrer Magnetic, Thermolyne type Model S7225 or 7200 (nosubstitutions). Permanently inscribe a circle 3.5 inches (8.9centimeter) on the top surface of the stirrer. The center of the circlemust be coincident with the geometric center of the stirrer. StirringBar 2.5 inch (6.2 centimeter) TEFLON coated with spinning ring.Permanently mark one end of the bar with black ink for a distance of 0.5inch (1.2 centimeter) back from the tip. Thermometer 30 to 120° F. with1 degree divisions Timer Digital stopwatch Stroboscope Variable speedstroboscope, model 964 available from Strobette, Power Instrument, Inc.of Skokie, IL is suitable Beaker Kimax brand 2000 milliliter with spout(no substitution), Inscribe a fill mark at a height of 5.6 inches (14.3centimeters) from the flat bottom of the beaker. Do not use any beakernot having a flat bottom. Conditioned Room Temperature and humidityshould be controlled to remain within the following limits: Temperature:73 ± 3° F. (23° C. ± 2° C.) Humidity: 50 ± 2% Relative Humidity

Test Setup

1. Fill the beaker to the fill mark with 73±3° F. tap water.

2. Place the beaker on the magnetic stirrer centering it in theinscribed circle.

3. Add the stirring bar to the beaker.

4. Turn the stroboscope on and set the speed to 1000 rpm according tothe manufacturer's directions.

5. Turn the magnetic stirrer on with the on/off switch. Adjust the speedof the magnetic stirrer until the stirring bar appears to be stationaryand both ends appear to be black. This indicates that the magneticstirrer is turning at 500 rpm (i.e. half the setting on thestroboscope). Turn the magnetic stirrer off with the on/off switch.

Procedure

1. Hold a sample (e.g. an absorbent interlabial device 20) 3 to 4 inches(7.6 to 10.2 centimeters) above the surface of the water. Gently dropthe sample onto the water surface, starting the timer when the sampletouches the water surface.

2. Wait 5 seconds.

3. Start the magnetic stirrer with the on/off switch.

4. Record the time required until the sample separates into at least twopieces. If the motion of the stirring bar is disrupted by the sample soit no longer rotates, turn off the magnetic stirrer. Recenter the magnetwithout removing the sample and restart the stirrer immediately. Thetime recorded is the total time that the sample remains in the water,including the time required to restart the stirrer.

5. Repeat steps 1 through 4 with an additional 3 samples.

Calculation and Reporting

Calculate and report the mean and standard deviation of the waterdispersibility time for the four samples tested. However, if at leastone of the four samples separates into at least two fragments during thetime specified in the appended claims, the sample will be considered tobe water dispersible. The term “fragments” as used herein, is notintended to include the separation of merely a few loose fibers (thatis, fibers which constitute less than 5% of the total product mass) fromthe sample. The interlabial devices described herein preferably disperseinto at least two fragments within about 1 hour, more preferably withinabout 30 minutes.

This concludes the test.

Flushability

Overview

As noted above, the terms “flushable or flushability” refer to aproduct's capacity to pass through typical commercially availablehousehold toilets and plumbing drainage systems without causing cloggingor similar problems that can be directly associated with the physicalcharacteristics of the product. For the purpose of the appended claims,catamenial products are evaluated for flushability via relative ease oftoilet bowl and trap evacuation and subsequent transport through asimulated plumbing system. The flushability of such a device should bemeasured by the following test procedure.

The test procedure is designed to simulate two days of normal toiletusage for a family of 4 (2 men, 2 women). The test employs a flushingsequence to simulate the following conditions: male urination visits,female urination visits (including post urinary drying with tissue),disposal of catamenial product (that is, the interlabial device or otherdevice to be tested) with cleaning using tissue, and bowel movementvisits. The amount of tissue to be used for each tissue flush is anormal loading of 2 strips of seven sheets. The normal loading is basedon consumer research regarding typical habits and practices. The test isdesigned to simulate the conditions a product will encounter if it isflushed through a conventional toilet and into a municipal sewer or intoa septic tank. Samples are evaluated for: 1) toilet bowl and trapclearance, 2) drain line blockage, and 3) disintegration duringflushing.

Apparatus

An apparatus suitable for the flushability test is shown in plan view inFIG. 14. The apparatus includes:

a 3.5 gallon (13.2 liter) water saver siphon vortex toilet referred toas 210 (additional toilets can also be attached to the piping layoutshown in FIG. 14 to evaluate the behavior of test samples usingdifferent flushing mechanisms such as commercial, pressure toilets);

approximately 59 feet (18 meters) of 4 inch (10 cm) inside diameteracrylic pipe (As can be seen from FIG. 14, the piping is assembled inroughly a square configuration having linear runs 211, 213, 215, 217,219, 221 approximately 10 feet (3 meters) long);

a cast iron tee 223 slightly downstream of the toilet 210 that is opento the atmosphere for venting;

five cast iron ninety degree elbows 212, 214, 216, 218, and 220;

a snag 222 positioned vertically (FIG. 15) approximately 15 feet fromthe pipe's terminal end and approximately 1 inch (2.5 cm) long; and

a screen (No. 4 Tyler sieve) to capture solid effluent for evaluation ofdisintegration.

The apparatus used for this method is set up to be equivalent to ANSIStandard A112.19.2M-1990 for Vitreous China fixtures. The piping isplumbed to provide a drop of 0.25 inch per foot (2 centimeters/meter) ofpipe length.

Materials

Tissue Product used in Test: standard CHARMIN® toilet tissuemanufactured by

The Procter & Gamble Company of Cincinnati, Ohio.

Synthetic Fecal Material Prepared according to the method describedbelow

Test Flushing Sequence

The test flushing sequence simulates 2 days of normal toilet usage for afamily of 4 (2 men, 2 women; based on consumer habits and practicesresearch). The sequence of 34 total flushes consists of 14 flushes withan empty bowl, 8 flushes with tissue only, 6 flushes with tissue and acatamenial product and 6 flushes with tissue and simulated fecal matter(SFM). When it is used, the SFM is placed in the bowl just prior to theaddition of tissue. The SFM loading of 160 g ±5 g consists of two 1 inch(2.5 centimeter)×4 inch (10 centimeter) pieces and one 1 inch (2.5centimeter) ×2 inch (5 centimeter) piece. Folded tissue strips (or thecatamenial product) are placed in the bowl at 10 second intervals. Tenseconds after the final strip or catamenial product is placed into thebowl, the toilet is flushed. The flushing sequence is described below asa series of two routines combined in the following order:

Routine #1 (To be performed first 6 times for a total of 30 flushes)

1) Flush With Tissue Only—Take a drain line blockage reading 2 minutesafter the water reaches the simulated obstruction, wait 1 additionalminute, and move to step 2.

2) Flush With Empty Bowl. Take a drain line blockage reading 2 minutesafter the water reaches the snag point and move to step 3.

13) Flush With Tissue and Catamenial Product—Take a drain line blockagereading 2 minutes after the water reaches the snag point, wait 1additional minute, and move to step 4.

4) Flush With Empty Bowl. Take a drain line blockage reading 2 minutesafter the water reaches the snag point and move to step 5.

5) Flush With Tissue and Simulated Fecal Matter (SFM). Take a drain lineblockage reading 2 minutes after the water reaches the snag point, wait1 additional minute.

Routine #2 (To be performed 1 time)

1) Flush With Tissue Only—Take a drain line blockage reading 2 minutesafter the water reaches the snag point, wait 1 additional minute, andmove to step 2.

2) Flush With Empty Bowl. Take a drain line blockage reading 2 minutesafter the water reaches the snag point and move to step 3.

3) Flush With Tissue Only—Take a drain line blockage reading 2 minutesafter the water reaches the snag point, wait 1 additional minute, andmove to step 4.

4) Flush With Empty Bowl. Take a drain line blockage reading 2 minutesafter the water reaches the snag point.

Total number of flushes per sequence is 34.

If, after the second flush in the flushing sequence, the product remainsin the bowl or trap after flushing, the tissue and or catamenial productis plunged into the drainage line manually and the flushing sequencewill continue. After completion of each trial loading, the drainage pipewill be cleared prior to beginning subsequent testing.

The above described flushing sequence is repeated three times for eachtest product.

Data Reporting

The degree of drain line blockage is determined by measuring the lengthof water dammed up behind the obstruction. Graduations are marked every12 inches (30 centimeters) on the drainpipe upstream of the obstruction.Each one foot length that the water is backed up corresponds to 0.25inch (0.6 centimeter) or 6.25% of blockage at the obstruction point.Test product residues which exit the drainpipe are also collected.

The following data are recorded for each evaluation:

1) Incidence of failure (%) of catamenial product to clear bowl and trapin one flush

2) Incidence of failure (%) of catamenial product to clear bowl and trapin two flushes

3) Incidence of product on simulated snag

4) Maximum level (%) of drain line blockage

5) Cumulative level (%) of drain line blockage over the 2 day simulatedtest period.

Preferably, the products described herein will completely clear the bowlat least about 70% of the time in two or fewer flushes, more preferablyat least about 80% of the time in one flush, and most preferably atleast about 95% of the time in one flush. The products described hereinwill preferably have a maximum level of drain line blockage of less thanor equal to about 80%. The products described herein will preferablyhave a cumulative level of drain line blockage over the 2 day simulatedtest period of less than or equal to about 50%.

Preparation of Synthetic Fecal Material

I. Materials Needed:

Feclone synthetic fecal matter (900 grams); (Available from SilicloneStudio, Valley Forge, PA as product BFPS-7 dry concentrate )

Tap water at 100° C. (6066 grams)

II. Equipment Needed:

Mixer (Available from Hobart Corp., Troy, OH as Model A200)

Extruder (Available from Hobart Corp., Troy, OH as Model 4812)

Disposable Centrifuge tubes with screw caps (50 ml) (Available from VWRScientific, Chicago, Ill. as Catalog No. 21-008-176)

Water Bath to control temperature to 37° C.

III. Preparation:

1. Pour the 100° C. water into the mixing bowl of the mixer and add thedry Feclone concentrate.

2. Mix on low for 1 minute.

3. Mix on medium speed for 2 minutes.

4. After the material is well mixed, transfer to the extruder.

5. Using an ice pick, punch a small hole in the tip of each centrifugetube.

6. Extrude the Feclone into the centrifuge tubes.

7. Cap the centrifuge tubes and store in the refrigerator.

8. Before using, put the tubes in the water bath at 38° C.

SPECIFIC ILLUSTRATIONS OF THE PREPARATION OF EMOLLIENT-TREATEDINTERLABIAL DEVICES

The following are specific illustrations of interlabial devices withemollient compositions in accordance with the present invention:

Example 1

A. Preparation of Emollient Compositions

A water free emollient composition (Emollient A) is made by mixing thefollowing melted (i.e., liquid) components together: Mineral Oil(Carnation White Mineral Oil, USP made by Witco Corp.), Cetearyl Alcohol(a mixed linear C₁₆-C₁₈ primary alcohol made by the Procter & GambleCompany under the name TA-1618); Steareth-2 (Brij 72, a C₁₈ linearalcohol ethoxylate having an average degree of ethoxylation of 2, madeby ICI America). The weight percentages of these components are shown inTable I below:

TABLE I Component Weight % Mineral Oil 50 Cetearyl Alcohol 35 Steareth-215

B. Preparation of Emollient-Treated Interlabial Device by Hot MeltSpraying

Emollient Composition A is placed into a heated tank operating at atemperature of 125° F. T he composition is subsequently sprayed (using aDynatec E84B1758 spray head, operating at a temperature of 165° F. andan atomization pressure of 2.40 psig) onto the body-contacting surfaceof the interlabial device. Add-on level=2.3 mg/cm²).

Example 2

A. Preparation of Emollient Compositions

A water free emollient composition (Emollient B) is made by mixing thefollowing melted (i.e., liquid) components together: Mineral Oil(Carnation White Mineral Oil, USP made by Witco Corp.), and CetearylAlcohol (a mixed linear C₁₆-C₁₈ primary alcohol made by the Procter &Gamble Company under the name TA-1618). The weight percentages of thesecomponent s are shown in Table II below:

TABLE II Component Weight % Mineral Oil 65 Cetearyl Alcohol 35

B. Preparation of Emollient-Treated Interlabial Device by Hot MeltSpraying

Emollient Composition B is placed into a heated tank operating at atemperature of 125° F. The composition is subsequently sprayed (using aDynatec E84B1758 spray head, operating at a temperature of 165° F. andan atomization pressure of 2.40 psig) body-contacting surface of theinterlabial device. Add-on level=0.006 g/in² (2.3 mg/cm²).

Example 3

A. Preparation of Emollient Composition

A water free emollient composition (Emollient C) is made by mixing thefollowing melted (i.e., liquid) components together: White Protopet® 1S(white petrolatum made by Witco Corp.), Cetearyl Alcohol (a mixed linearC₁₆-C₁₈ primary alcohol made by the Procter & Gamble Company under thename TA-1618); Cetearth 10 (a blend or mixture of C_(16 and C) ₁₈alcohols ethoxylated to an average of 10 ethoxylate units obtained fromBASF Corp. of Mount Olive, N.J.). The weight percentages of thesecomponents are shown in Table I below:

A water free emollient composition (Emollient C) is made by mixingtogether the following melted (i.e., liquid) components in the weightpercentages shown in the Table III below according to the procedure ofExample 2:

TABLE III Component Weight % WhiteProtopet ® 50 1S Cetearyl Alcohol 35Cetearth-10 15

B. Preparation of Emollient-Treated Interlabial Device by Hot MeltSpraying

Emollient Composition C is placed into a heated tank operating at atemperature of 125° F. The composition is subsequently sprayed (using aDynatec E84B1758 spray head, operating at a temperature of 165° F. andan atomization pressure of 2.40 psig) body-contacting surface of theinterlabial device. Add-on level=0.004 glin² (1.5 mg/cm²).

Example 4

A. Preparation of Emollient Composition

A water free emollient composition (Emollient D) is made by mixing thefollowing melted (i.e., liquid) components together: White Protopet® 1S(white petrolatum made by Witco Corp.); Dow Corning 556 Cosmetic GradeFluid(a polyphenylmethylsiloxane made by the Dow Corning Corporation),An example of a particularly preferred paraffin wax is Parrafin S.P. 434(a paraffin wax made by Strahl and Pitsch Inc.); Cetearyl Alcohol (amixed linear C₁₆-C₁₈ primary alcohol made by the Procter & GambleCompany under the name TA-1618); PEG 2000 (a polyethylene glycol havinga MW of 2000 made by Sigma-Aldrich Corp). The weight percentages ofthese components are shown in Table IV below:

TABLE IV Component Weight % WhiteProtopet ® 52 1S Polyphenylmethyl- 10siloxane Paraffin Wax 15 Cetearyl Alcohol 20 PEG 2000  3

B. Preparation of Emollient-Treated Interlabial Device by Hot MeltSpraying Emollient Composition D is placed into a heated tank operatingat a temperature of 150° F. The composition is subsequently sprayed(using a Dynatec E84B1758 spray head, operating at a temperature of 170°F. and an atomization pressure of 2.40 psig) body-contacting surface ofthe interlabial device. Add-on level=0.006 g/in² (2.3 mg/cm²).

While particular embodiments of the present invention have beenillustrated and described, it would be obvious to those skilled in theart that various other changes and modifications can be made withoutdeparting from the spirit and scope of the invention.

What is claimed is:
 1. An absorbent device for wearing in theinterlabial space of a female wearer, said absorbent device having abody-contacting surface at least a portion of which is capable ofmaintaining contact with the inside surfaces of the wearer's labia whenthe absorbent device is worn, and an absorbent portion, wherein at leasta portion of said body-contacting surface comprises an emollientcomposition, said emollient composition comprising a substantiallywater-free emollient, said emollient composition being free ofhydrocarbon components having a molecular weight greater than or equalto 1,500, wherein at least a portion of said emollient compositionremains on said body-contacting surface without being absorbed into saidabsorbent device, and wherein said absorbent device is sufficientlyflushable that it completely clears the bowl under the Flushability Testat least about 70% of the time in two or fewer flushes.
 2. An absorbentinterlabial device according to claim 1 that is sufficiently flushablethat it completely clears the bowl under the Flushability Test at leastabout 95% of the time in one flush.
 3. An absorbent device for wearingin the interlabial space of a female wearer, said absorbent devicehaving a body-contacting surface at least a portion of which is capableof maintaining contact with the inside surfaces of the wearer's labiawhen the absorbent device is worn, and an absorbent portion, wherein atleast a portion of said body-contacting surface comprises an emollientcomposition, said emollient composition comprising a substantiallywater-free emollient, said emollient composition being free ofhydrocarbon components having a molecular weight greater than or equalto 1,500, wherein at least a portion of said emollient compositionremains on said body-contacting surface without being absorbed into saidabsorbent device, and wherein said absorbent device disperses into atleast two fragments as measured by the Water Dispersion Test in lessthan or equal to about one hour.